{"meta":{"query_hash":"6cd95c356a07","filters":{"venue":"Seminars in Oncology"},"cohort_total":87,"direct_labels_cover":0,"predictions_cover":87,"exported":87,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/6cd95c356a07","api":"https://metacan.xera.ac/api/v1/cohort?venue=Seminars+in+Oncology"},"results":[{"id":"W1968524867","doi":"10.1053/j.seminoncol.2010.06.001","title":"Zoledronic Acid Use in Patients With Bone Metastases From Renal Cell Carcinoma or Bladder Cancer","year":2010,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Novartis Pharmaceuticals Corporation; Novartis","keywords":"Medicine; Zoledronic acid; Renal cell carcinoma; Cancer; Placebo; Internal medicine; Oncology; Bladder cancer; Bone disease; Urology; Kidney cancer; Surgery; Pathology; Osteoporosis","score_opus":0.042164820549838965,"score_gpt":0.3604882786700274,"score_spread":0.3183234581201885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968524867","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12613082,0.8706413,3.5452805e-7,0.000049057366,0.0004361183,0.001940181,0.0005702779,0.000018338851,0.00021353726],"genre_scores_gemma":[0.0032946619,0.9910345,0.0015698462,0.00033918652,0.000102998056,0.00080145284,0.001516762,0.00010332845,0.0012372668],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99698323,0.00032309716,0.00092376524,0.00074502657,0.00028102015,0.00074388727],"domain_scores_gemma":[0.99798995,0.00049924676,0.00052843406,0.00059345405,0.0000731164,0.00031580983],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019041488,0.0005795222,0.0029824292,0.0004599712,0.000041027237,0.000009247381,0.00015138772,0.0009397708,0.0006493631],"category_scores_gemma":[0.00008430588,0.0003707609,0.00016249498,0.00045171764,0.00014474882,0.00008116708,0.000092885195,0.0015169019,0.000063843065],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013829807,0.0018655872,0.07635058,0.0021105309,0.00014655422,0.0026325325,0.00012646167,1.6678035e-7,6.0060506e-7,7.733716e-7,0.0016953677,0.9136879],"study_design_scores_gemma":[0.008815361,0.0029190613,0.014522417,0.007661956,0.002060693,0.00007215328,0.000015564154,9.395589e-7,0.000010284678,0.000003526534,0.9635612,0.00035687897],"about_ca_topic_score_codex":0.004570643,"about_ca_topic_score_gemma":0.027761286,"teacher_disagreement_score":0.9618658,"about_ca_system_score_codex":0.0014649222,"about_ca_system_score_gemma":0.0038383827,"threshold_uncertainty_score":0.9998744},"labels":[],"label_agreement":null},{"id":"W1975826537","doi":"10.1053/j.seminoncol.2004.03.042","title":"The role of COX-2 inhibition in breast cancer treatment and prevention","year":2004,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":233,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Celecoxib; Aromatase; Breast cancer; Exemestane; Internal medicine; Oncology; Cancer; Angiogenesis; Cancer research","score_opus":0.0147704007122809,"score_gpt":0.3580283085129214,"score_spread":0.34325790780064047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975826537","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016027367,0.98205996,2.0238586e-7,0.00007825624,0.00019193499,0.0011669121,0.000017973942,0.000005887139,0.00045151665],"genre_scores_gemma":[0.0013568746,0.9978123,0.000023954362,0.000009315456,0.00011633441,0.0004954192,0.00003642843,0.00001903169,0.0001303632],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998814,0.00022776867,0.0004714431,0.00020543739,0.00008005655,0.0002012825],"domain_scores_gemma":[0.99925894,0.0002582901,0.00026285445,0.00014877484,0.000022880919,0.000048285972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004142611,0.00019228293,0.0010605633,0.00017676088,0.000025553181,0.000002598976,0.00002987282,0.0003765777,0.000016129976],"category_scores_gemma":[0.000028028397,0.00012058993,0.00011508207,0.00017660084,0.000119027034,0.000019917048,0.000026419397,0.00023731918,0.000003568621],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084959414,0.0001607956,0.0006806952,0.0032204397,0.000036608883,0.00010710837,0.00022860689,6.7600894e-7,0.000008074413,0.0001060326,0.000028458922,0.99533755],"study_design_scores_gemma":[0.0022238132,0.0012859879,0.00071967294,0.056117374,0.0005117539,0.00077367306,0.000145325,0.0000048601414,0.00007237565,0.00057488994,0.9374131,0.00015720088],"about_ca_topic_score_codex":0.00020138208,"about_ca_topic_score_gemma":0.0007029427,"teacher_disagreement_score":0.99518037,"about_ca_system_score_codex":0.0015570949,"about_ca_system_score_gemma":0.0010135683,"threshold_uncertainty_score":0.49175146},"labels":[],"label_agreement":null},{"id":"W1980747619","doi":"10.1053/j.seminoncol.2009.10.014","title":"Clinical Development of Temsirolimus, a Novel mTOR Inhibitor, for Treatment of Advanced Malignancies","year":2009,"lang":"en","type":"editorial","venue":"Seminars in Oncology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Temsirolimus; Discovery and development of mTOR inhibitors; Medicine; PI3K/AKT/mTOR pathway; Sirolimus; Oncology; Cancer research; Internal medicine; Signal transduction","score_opus":0.023576499897532133,"score_gpt":0.371626267336534,"score_spread":0.34804976743900184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980747619","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32423714,0.016327802,0.0008330985,0.00008135886,0.65432656,0.0023077915,0.0011096266,0.000025341204,0.00075130403],"genre_scores_gemma":[0.021917649,0.01600855,0.23659043,0.0001525844,0.7137286,0.0017285444,0.0041318927,0.000301152,0.0054405797],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99670005,0.00010663339,0.0016239966,0.0007977351,0.0003061022,0.00046547552],"domain_scores_gemma":[0.99726295,0.00067155954,0.0010317102,0.0005315041,0.0004109916,0.0000912701],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00076846033,0.00044186364,0.0013819505,0.00015253127,0.000036986003,0.000003975382,0.0004169479,0.0021875915,0.0000064378223],"category_scores_gemma":[0.0009952366,0.0004315883,0.0003387046,0.00011572687,0.00027883085,0.0000031268985,0.00011004876,0.00018726924,0.0000010778061],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033351155,0.0024929168,0.00033468645,0.0003028659,0.00032814077,0.000011244158,0.00044264272,0.000082812585,0.37113112,0.000011683883,0.4575875,0.16393925],"study_design_scores_gemma":[0.0041200276,0.009400465,0.00006954817,0.0003691041,0.00007031305,0.0000026461441,0.00006366645,0.000003587224,0.14645693,0.000025295223,0.839102,0.00031639021],"about_ca_topic_score_codex":0.000012377321,"about_ca_topic_score_gemma":0.00017681197,"teacher_disagreement_score":0.38151452,"about_ca_system_score_codex":0.0005186023,"about_ca_system_score_gemma":0.0033805051,"threshold_uncertainty_score":0.9998136},"labels":[],"label_agreement":null},{"id":"W1984740505","doi":"10.1053/sonc.2002.30143","title":"Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma","year":2002,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Mantle cell lymphoma; Autologous stem-cell transplantation; Transplantation; Surgery; Cyclophosphamide; Internal medicine; Vincristine; Chemoimmunotherapy; Oncology; Debulking; Chemotherapy; Lymphoma; Cancer; Ovarian cancer","score_opus":0.016037350853888393,"score_gpt":0.26521463581250715,"score_spread":0.24917728495861877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984740505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810701,0.014820286,0.000052405227,0.00076476234,0.00017451205,0.000977578,0.000014836646,0.00004023731,0.002085295],"genre_scores_gemma":[0.9775504,0.016175559,0.004307318,0.00059909426,0.00003587459,0.00035681628,0.000032463628,0.000034729343,0.0009077864],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989245,0.000060440503,0.0002495651,0.0003362309,0.000116975134,0.0003122966],"domain_scores_gemma":[0.99930745,0.0003282149,0.000090548565,0.00018356262,0.000023544313,0.00006669013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001343633,0.00020540076,0.00049500895,0.000121190045,0.00008167397,0.000012090898,0.00006113691,0.00018481907,0.000046065143],"category_scores_gemma":[0.0000018262625,0.00015625615,0.00008126329,0.00011067055,0.000065159395,0.000058341564,0.0000065217214,0.00005602278,0.000012387828],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033510874,0.007060202,0.032415193,0.00014049666,0.0001662639,0.0019796125,0.0046890792,0.0000066247135,0.0053798165,0.00009967645,0.0009099825,0.94380194],"study_design_scores_gemma":[0.44044825,0.04273662,0.30373058,0.00088064617,0.00088976015,0.0026774488,0.0025951182,0.0013091615,0.12758216,0.0004821308,0.07536379,0.0013043276],"about_ca_topic_score_codex":0.0000975894,"about_ca_topic_score_gemma":0.000043350476,"teacher_disagreement_score":0.9424976,"about_ca_system_score_codex":0.0002921015,"about_ca_system_score_gemma":0.00006905984,"threshold_uncertainty_score":0.63719404},"labels":[],"label_agreement":null},{"id":"W1986647178","doi":"10.1016/s0093-7754(03)00171-4","title":"Treatment of cancer-related hypercalcemia: The role of gallium nitrate","year":2003,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Calcitonin; Bone resorption; Internal medicine; Endocrinology","score_opus":0.04123986567245706,"score_gpt":0.41195496175165386,"score_spread":0.3707150960791968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986647178","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014011028,0.9789823,3.139381e-8,0.00011650394,0.00031476762,0.0016530149,0.000049862476,0.000012313699,0.017470064],"genre_scores_gemma":[0.00045464264,0.99716246,0.00016563357,0.000039629664,0.000025707795,0.00049238285,0.00006598467,0.000038413695,0.0015551392],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99784684,0.00033080723,0.0010144238,0.0003030428,0.00014224467,0.00036262517],"domain_scores_gemma":[0.9983485,0.00042839054,0.00061188155,0.0004321901,0.00006404267,0.00011502239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016534478,0.00033656444,0.0026957085,0.00018386003,0.000028620063,9.62629e-7,0.00010907327,0.00078367227,0.00012517224],"category_scores_gemma":[0.000029702376,0.00019280314,0.00035791672,0.00041727847,0.00016236737,0.000010178977,0.000018441451,0.00034536328,0.000020821453],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089650566,0.0014698961,0.001571887,0.0028451404,0.00049192354,0.00015161339,0.00030171225,2.6289752e-7,0.0000021285891,0.00008817258,0.00010005987,0.99288756],"study_design_scores_gemma":[0.0017866787,0.002967153,0.00008458179,0.0046906006,0.002712491,0.00034089995,0.00007184395,0.0000025153356,0.000035478184,0.000104096456,0.9870982,0.00010545699],"about_ca_topic_score_codex":0.0009824254,"about_ca_topic_score_gemma":0.0002705876,"teacher_disagreement_score":0.9927821,"about_ca_system_score_codex":0.0014017314,"about_ca_system_score_gemma":0.002520247,"threshold_uncertainty_score":0.78622836},"labels":[],"label_agreement":null},{"id":"W1988586595","doi":"10.1053/sonc.2003.50017","title":"Thoracic radiotherapy for limited-stage small cell lung cancer: Issues of timing, volumes, dose, and fractionation","year":2003,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Radiation therapy; Medicine; Chemotherapy; Dose fractionation; Randomized controlled trial; Oncology; Lung cancer; Stage (stratigraphy); Internal medicine; Surgery","score_opus":0.08208530181503791,"score_gpt":0.4927384745917523,"score_spread":0.41065317277671437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988586595","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015951955,0.9938997,0.00006298019,0.00034725608,0.00041143634,0.003112685,0.00010980541,0.000022446817,0.0018741839],"genre_scores_gemma":[0.000003963595,0.97481865,0.0062608793,0.00010583522,0.0002628799,0.0012948908,0.000101950485,0.0000716998,0.017079243],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99793583,0.00027794717,0.0006472966,0.00051060144,0.0002271045,0.00040121382],"domain_scores_gemma":[0.9978862,0.001003414,0.0005227724,0.00029457486,0.00020185768,0.000091219146],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00078760897,0.00034144614,0.0021244958,0.00052794267,0.00006639176,0.000009222139,0.00014654594,0.00054930645,0.0001206163],"category_scores_gemma":[0.0002754319,0.00029561188,0.00020161679,0.0003848796,0.00020581386,0.000047544596,0.000057994133,0.0005554517,0.0000011697748],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015619071,0.00019265398,0.0010970702,0.04467922,0.00033318315,0.000034553465,0.00049208757,0.0000029213252,0.0000127876065,0.000025691576,0.023904575,0.92906904],"study_design_scores_gemma":[0.0010105087,0.00090607983,0.000049291055,0.009595905,0.00067773345,0.00003534765,0.000119698234,0.00013620823,0.00001968838,0.000011973319,0.9872271,0.00021049159],"about_ca_topic_score_codex":0.00022209251,"about_ca_topic_score_gemma":0.00022133117,"teacher_disagreement_score":0.9633225,"about_ca_system_score_codex":0.0020014462,"about_ca_system_score_gemma":0.0013436488,"threshold_uncertainty_score":0.9999496},"labels":[],"label_agreement":null},{"id":"W1991788040","doi":"10.1053/j.seminoncol.2007.10.006","title":"Clinical Benefits and Considerations of Bisphosphonate Treatment in Metastatic Bone Disease","year":2007,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Zoledronic acid; Prostate cancer; Breast cancer; Oncology; Multiple myeloma; Internal medicine; Bone pain; Bone disease; N-terminal telopeptide; Bone resorption; Bisphosphonate; Osteoporosis; Cancer; Alkaline phosphatase; Osteocalcin","score_opus":0.17224841962941687,"score_gpt":0.49897491703155994,"score_spread":0.3267264974021431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991788040","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004999863,0.992115,3.871138e-7,0.00023739443,0.00021903707,0.0019184076,0.00011130564,0.000009342649,0.00038925122],"genre_scores_gemma":[0.00074350106,0.9960253,0.0022218626,0.00021679471,0.000015317106,0.00027323337,0.00017031579,0.000029012577,0.00030464344],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971954,0.00032231648,0.001575211,0.000441454,0.000118692784,0.00034687738],"domain_scores_gemma":[0.99659413,0.002295638,0.0003935272,0.0002959116,0.000038902977,0.00038191135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065196195,0.00030828625,0.003006266,0.00044782195,0.000025121111,0.0000024087167,0.00003017882,0.00034036336,0.000056806977],"category_scores_gemma":[0.0004603889,0.00023441603,0.00022410201,0.00027709585,0.00020800433,0.00001974102,0.00003712939,0.0003531675,0.000014047544],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001872917,0.0019721116,0.011158758,0.0032236201,0.00013410219,0.0035350109,0.00007269445,3.6223904e-7,9.932327e-9,0.00022108707,0.00011126727,0.9793837],"study_design_scores_gemma":[0.006245511,0.0032034426,0.007877148,0.016608816,0.0026722879,0.0006538157,0.00003401846,0.0000077388695,4.48725e-7,0.0003145032,0.96216094,0.00022133256],"about_ca_topic_score_codex":0.0004396785,"about_ca_topic_score_gemma":0.0023023856,"teacher_disagreement_score":0.97916234,"about_ca_system_score_codex":0.000631686,"about_ca_system_score_gemma":0.0024206934,"threshold_uncertainty_score":0.9559208},"labels":[],"label_agreement":null},{"id":"W1994549184","doi":"10.1053/j.seminoncol.2010.05.008","title":"The Role of Physical Activity in Breast Cancer Etiology","year":2010,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Physical Activity and Health","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Breast cancer; Observational study; Population; Cancer; Randomized controlled trial; Epidemiology; Cancer prevention; Incidence (geometry); Gerontology; Internal medicine; Demography; Physical therapy; Environmental health","score_opus":0.03902035306381191,"score_gpt":0.43838135601563033,"score_spread":0.3993610029518184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994549184","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02131264,0.97222966,2.3028494e-7,0.0013666775,0.00028011593,0.00080304575,0.000069328125,0.000011175214,0.003927153],"genre_scores_gemma":[0.010004229,0.98910403,0.000014373595,0.000044917757,0.0004536824,0.00026344342,0.000009341782,0.000022762546,0.00008322085],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99831533,0.0004655144,0.00033860758,0.0003348982,0.00012471736,0.00042090844],"domain_scores_gemma":[0.99709314,0.0020929875,0.0003474,0.00034117486,0.00003628375,0.00008900372],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00042174628,0.00023743768,0.0025710769,0.00013914116,0.000038825518,0.000001939945,0.00021875546,0.0007441658,0.000020276171],"category_scores_gemma":[0.00010653397,0.00015060017,0.00025578408,0.0003420746,0.00043371192,0.000030525443,0.00011748384,0.002484872,0.000014323151],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016525298,0.0018379805,0.0002372476,0.0017624673,0.000027203729,0.000022948932,0.00014255574,1.7936443e-7,0.00013093618,0.000701579,0.00009331363,0.99487835],"study_design_scores_gemma":[0.00036049643,0.0005308812,0.0011855586,0.0043088035,0.00014531286,0.0001191241,0.000026730364,0.000032983877,0.000021548405,0.0008807363,0.9922685,0.00011932679],"about_ca_topic_score_codex":0.0005779774,"about_ca_topic_score_gemma":0.0015157184,"teacher_disagreement_score":0.994759,"about_ca_system_score_codex":0.0005952557,"about_ca_system_score_gemma":0.0017335098,"threshold_uncertainty_score":0.9998164},"labels":[],"label_agreement":null},{"id":"W1998463059","doi":"10.1053/j.seminoncol.2013.07.006","title":"Initial Treatment of Transplant Candidates With Multiple Myeloma","year":2013,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Lenalidomide; Multiple myeloma; Thalidomide; Bortezomib; Autologous stem-cell transplantation; Oncology; Internal medicine; Toxicity; Transplantation; Surgery","score_opus":0.06313384381745932,"score_gpt":0.40425614925885506,"score_spread":0.34112230544139577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998463059","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0049288333,0.9878572,0.0000022843863,0.0000405323,0.00008465209,0.003062018,0.00028445292,0.000024441177,0.0037155438],"genre_scores_gemma":[0.0035847137,0.991897,0.0011838129,0.000009832129,0.00009319402,0.0012725353,0.0010561602,0.00006444041,0.00083833403],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977042,0.0002548933,0.00069676305,0.00049508637,0.00027181525,0.00057720824],"domain_scores_gemma":[0.9980653,0.0008907547,0.00027366754,0.00044033822,0.000066335044,0.00026360643],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000107377855,0.00051312667,0.0030792535,0.0004992861,0.000034003075,0.0000062589515,0.00014733127,0.0005211542,0.00030387338],"category_scores_gemma":[0.00005304509,0.00030361966,0.00030243152,0.0003047964,0.0002648171,0.000036389665,0.000027258702,0.00029053105,0.000110339955],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076806796,0.001597418,0.0057731792,0.004770001,0.0007521622,0.004301802,0.00031076753,1.6429523e-7,0.000004770732,0.0000075307903,0.00013084755,0.9815833],"study_design_scores_gemma":[0.0073078694,0.012487351,0.00032769074,0.014584156,0.001272638,0.0017218115,0.00006599461,0.000021829821,0.0001307295,0.000005150286,0.9618007,0.00027407138],"about_ca_topic_score_codex":0.0007140261,"about_ca_topic_score_gemma":0.0010235163,"teacher_disagreement_score":0.98130924,"about_ca_system_score_codex":0.0011283985,"about_ca_system_score_gemma":0.0014693432,"threshold_uncertainty_score":0.9999416},"labels":[],"label_agreement":null},{"id":"W1999139776","doi":"10.1016/s0093-7754(01)90077-6","title":"The importance of drug diversity in the treatment of small cell lung cancer","year":2001,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Etoposide; Cisplatin; Oncology; Lung cancer; Drug; Chemotherapy; Population; Internal medicine; Combination chemotherapy; Pharmacology","score_opus":0.03271828028642188,"score_gpt":0.3800493503969207,"score_spread":0.34733107011049885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999139776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9622897,0.023990385,6.1441426e-7,0.004473622,0.00009862714,0.0005777409,0.0000062292447,0.000003212986,0.0085598985],"genre_scores_gemma":[0.93098736,0.0671287,0.00006311841,0.0001406767,0.000044392607,0.00009887599,0.0000014213475,0.0000047333665,0.0015307349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908656,0.00013060361,0.00022039415,0.00013954661,0.00017698093,0.00024592024],"domain_scores_gemma":[0.9988679,0.00069429213,0.000107813124,0.00024988325,0.000055075943,0.000025008929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048131178,0.000081342834,0.00030067813,0.00006050091,0.0000704583,0.0000011599095,0.00019050953,0.000046888814,0.000029035633],"category_scores_gemma":[0.00006162815,0.000043705546,0.00005342431,0.00026116436,0.00027541126,0.000012880342,0.00010887763,0.00012936679,5.791288e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047741598,0.00052430044,0.96883696,0.00005645409,0.00004259294,0.00019701071,0.016425531,0.00001571894,0.0001568512,0.000030756426,0.0036963846,0.009539999],"study_design_scores_gemma":[0.006559342,0.0030702478,0.8875811,0.00029586905,0.00018893916,0.000027581236,0.017043784,0.00020646668,0.002940427,0.00032047974,0.08163454,0.00013122089],"about_ca_topic_score_codex":0.002729933,"about_ca_topic_score_gemma":0.026379898,"teacher_disagreement_score":0.081255876,"about_ca_system_score_codex":0.00089835504,"about_ca_system_score_gemma":0.00023133888,"threshold_uncertainty_score":0.9913861},"labels":[],"label_agreement":null},{"id":"W2000894976","doi":"10.1053/j.seminoncol.2005.07.017","title":"Brief Communication: A New Combination in the Treatment of Advanced Pancreatic Cancer","year":2005,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Gemcitabine; Medicine; Pancreatic cancer; Erlotinib; Oncology; Internal medicine; Chemotherapy; Cancer; Antimetabolite; Epidermal growth factor receptor","score_opus":0.038405063507172994,"score_gpt":0.40898494403717806,"score_spread":0.37057988053000507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000894976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9460312,0.010007612,0.0000073723845,0.018993365,0.00003438966,0.00084420247,0.0000022004485,0.00001146226,0.024068175],"genre_scores_gemma":[0.9592612,0.030831492,0.00545233,0.00064003275,0.000068164474,0.000350671,0.000022309134,0.0000093696335,0.0033644515],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99878454,0.0002966529,0.0003795354,0.00015107106,0.00016183312,0.00022635255],"domain_scores_gemma":[0.9984535,0.0009431091,0.000109722925,0.00038695286,0.000053005617,0.000053739637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044769165,0.00010018365,0.0005233036,0.0001520866,0.00003338531,0.000002453744,0.00016296131,0.00014055535,0.00023984478],"category_scores_gemma":[0.00013258112,0.00007083672,0.000044964203,0.0003346323,0.00018926365,0.0000436743,0.000019164532,0.0001738239,0.00001047786],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093778514,0.0035918704,0.45014194,0.000036978185,0.00006268977,0.00006215602,0.017861672,0.00006470183,0.00049754215,0.0014307911,0.0039416375,0.52137023],"study_design_scores_gemma":[0.022155832,0.009866514,0.6622376,0.0006343265,0.00027499165,0.00016942031,0.005389936,0.0030326182,0.00076709787,0.0019025702,0.2933829,0.0001862131],"about_ca_topic_score_codex":0.0013901503,"about_ca_topic_score_gemma":0.0044912198,"teacher_disagreement_score":0.521184,"about_ca_system_score_codex":0.0009564221,"about_ca_system_score_gemma":0.0006247723,"threshold_uncertainty_score":0.28886378},"labels":[],"label_agreement":null},{"id":"W2002858168","doi":"10.1053/j.seminoncol.2003.12.002","title":"Integrating Monoclonal Antibodies into the Management of Mantle Cell Lymphoma","year":2004,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Mantle cell lymphoma; Autologous stem-cell transplantation; Oncology; Internal medicine; Transplantation; Chemotherapy; Clinical trial; Surgery; Maintenance therapy; Lymphoma","score_opus":0.011499077761637565,"score_gpt":0.3028536267254322,"score_spread":0.29135454896379465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002858168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9560026,0.0029489521,0.000018610739,0.0019748777,0.00015386217,0.00031103397,0.0000017103723,0.000013291062,0.038575068],"genre_scores_gemma":[0.9792343,0.0024851926,0.017465448,0.00030098812,0.00003193964,0.000069716785,0.000009638605,0.0000100622965,0.00039270814],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991654,0.00003153713,0.0002800049,0.00019090992,0.00013631309,0.00019581424],"domain_scores_gemma":[0.99950606,0.00010869079,0.00009539151,0.00022136889,0.00002997338,0.000038499093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018901844,0.00012255613,0.00028769934,0.00007938625,0.000050056788,0.0000041556664,0.000108502376,0.00008091245,0.00002962928],"category_scores_gemma":[0.000010448339,0.00007768345,0.000074892334,0.00015531752,0.00014017399,0.00002369894,0.0000999055,0.000059372054,0.0000248362],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005032173,0.006759181,0.17616618,0.0004670734,0.00041380903,0.0035231528,0.015380705,0.00012492991,0.0029099812,0.020969927,0.0015481787,0.7712337],"study_design_scores_gemma":[0.04134235,0.006895991,0.6010589,0.0040228353,0.0009474838,0.00076392054,0.045374077,0.0002147281,0.22255982,0.015911961,0.060276553,0.0006314057],"about_ca_topic_score_codex":0.00040231185,"about_ca_topic_score_gemma":0.00014068464,"teacher_disagreement_score":0.7706023,"about_ca_system_score_codex":0.0006404192,"about_ca_system_score_gemma":0.00012103468,"threshold_uncertainty_score":0.3167839},"labels":[],"label_agreement":null},{"id":"W2003894443","doi":"10.1016/s0093-7754(01)90198-8","title":"Epirubicin in combination with the taxanes","year":2001,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Epirubicin; Medicine; Anthracycline; Cardiotoxicity; Taxane; Docetaxel; Doxorubicin; Breast cancer; Oncology; Metastatic breast cancer; Pharmacology; Internal medicine; Trastuzumab; Paclitaxel; Chemotherapy; Cancer","score_opus":0.020006710689128585,"score_gpt":0.3529680784910304,"score_spread":0.33296136780190183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003894443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9488957,0.00083398225,0.0000057707525,0.024617687,0.00013983512,0.00038742987,5.8243137e-7,0.000014034236,0.025104968],"genre_scores_gemma":[0.99322104,0.0008595435,0.00012817854,0.0019192772,0.00006719754,0.00010819276,0.000012010952,0.0000085897955,0.0036759588],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99937433,0.000091050075,0.00012888669,0.00014171429,0.00007171237,0.00019232924],"domain_scores_gemma":[0.99955016,0.00024534832,0.000049464026,0.00010353017,0.000021815875,0.00002966221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022014248,0.000081157625,0.00021263793,0.00012736738,0.000024086796,0.0000020492382,0.000056772402,0.000089751455,0.0002746425],"category_scores_gemma":[0.000018985345,0.00005139524,0.000017924063,0.0003252133,0.00011407559,0.000026257481,0.000016290238,0.00020309811,0.00001948055],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003347446,0.0025095907,0.80169076,0.000023410106,0.00004791886,0.0030251243,0.004021763,0.000065284934,0.0032809838,0.0006070909,0.022961862,0.15841876],"study_design_scores_gemma":[0.016357766,0.008252813,0.34208804,0.00014386469,0.00011166643,0.0012003686,0.0018697911,0.00026481264,0.0015101103,0.0006046857,0.62742645,0.0001696346],"about_ca_topic_score_codex":0.00029618843,"about_ca_topic_score_gemma":0.0038415827,"teacher_disagreement_score":0.6044646,"about_ca_system_score_codex":0.00035376687,"about_ca_system_score_gemma":0.0001168561,"threshold_uncertainty_score":0.30071425},"labels":[],"label_agreement":null},{"id":"W2004731110","doi":"10.1053/sonc.2003.50016","title":"Surgical treatment of small cell lung cancer","year":2003,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Chemoradiotherapy; Radiation therapy; Lung cancer; Chemotherapy; Surgery; Clinical trial; Oncology; Internal medicine","score_opus":0.07881713051370332,"score_gpt":0.48020935050552593,"score_spread":0.4013922199918226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004731110","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011887575,0.9671338,3.8165106e-7,0.0001084705,0.00041502024,0.0018415748,0.000048616363,0.000013843992,0.030319402],"genre_scores_gemma":[0.00000345566,0.9856022,0.0003218879,0.000020587086,0.00021555745,0.0011999541,0.000037611768,0.00004937508,0.012549399],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99769485,0.00037111656,0.00070052553,0.00048210294,0.00022166809,0.0005297647],"domain_scores_gemma":[0.9983022,0.00078824174,0.0002857781,0.00040047534,0.00008159232,0.00014169594],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029668235,0.00038819865,0.0035428382,0.00033594354,0.000025716805,0.0000024291585,0.00014796795,0.00053106115,0.00037452744],"category_scores_gemma":[0.000056254856,0.00026988055,0.0004491916,0.0004280073,0.00023035302,0.0000097674565,0.00008113637,0.0004055747,0.000014616171],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008514854,0.0008175832,0.0009993039,0.022714641,0.00039116733,0.0020907577,0.0003003054,6.469653e-7,4.565563e-7,0.000016286764,0.005565053,0.96701866],"study_design_scores_gemma":[0.0018828901,0.001973087,0.0000073650713,0.011936329,0.0013850876,0.00022946786,0.00004368176,0.0000021520414,0.000008696665,0.000003501934,0.982355,0.00017275767],"about_ca_topic_score_codex":0.00027807153,"about_ca_topic_score_gemma":0.00022785598,"teacher_disagreement_score":0.97678995,"about_ca_system_score_codex":0.005175904,"about_ca_system_score_gemma":0.0031190333,"threshold_uncertainty_score":0.9999753},"labels":[],"label_agreement":null},{"id":"W2011129605","doi":"10.1053/j.seminoncol.2010.06.007","title":"Maintaining Bone Health in Prostate Cancer Throughout the Disease Continuum","year":2010,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Zoledronic acid; Prostate cancer; Malignancy; Androgen deprivation therapy; Bone disease; Bone pain; Bisphosphonate; Bone metastasis; Cancer; Multiple myeloma; Disease; Bone Density Conservation Agents; Oncology; Internal medicine; Prostate; Osteoporosis; Surgery; Bone density","score_opus":0.04502589025133711,"score_gpt":0.4682166791827064,"score_spread":0.42319078893136924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011129605","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002762651,0.9810722,2.9883333e-7,0.012496045,0.0009489537,0.0038556382,0.00011074064,0.000029587765,0.0012102721],"genre_scores_gemma":[0.00010977674,0.99146247,0.0002266854,0.0035634344,0.00020223034,0.0018071168,0.0002525067,0.0000694829,0.0023062855],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968035,0.00051233894,0.0010712616,0.0005503491,0.0001650518,0.0008974805],"domain_scores_gemma":[0.997932,0.00050972356,0.0005966771,0.00052241347,0.000034928336,0.00040423524],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011011618,0.00040812153,0.0026459165,0.0002529444,0.00009312391,0.000008083901,0.00015534252,0.00040923333,0.00007211917],"category_scores_gemma":[0.00024162521,0.0002580171,0.000203391,0.00041968568,0.00021784709,0.000030696952,0.000099620185,0.0019827927,0.00004305775],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019389811,0.00034024162,0.0042653643,0.0043267133,0.00003476248,0.0014728013,0.00052681135,1.12777606e-7,2.9096757e-8,0.00006529571,0.0029759288,0.98579806],"study_design_scores_gemma":[0.0017756195,0.00046836043,0.0011828592,0.020256247,0.0002538403,0.00025880782,0.00008449423,0.000002309831,4.3718337e-8,0.00016081035,0.97539073,0.0001658952],"about_ca_topic_score_codex":0.0014657599,"about_ca_topic_score_gemma":0.010258808,"teacher_disagreement_score":0.9856321,"about_ca_system_score_codex":0.0019745543,"about_ca_system_score_gemma":0.007289727,"threshold_uncertainty_score":0.9999872},"labels":[],"label_agreement":null},{"id":"W2017801391","doi":"10.1016/s0093-7754(03)00348-8","title":"Conservative versus radical therapy of prostate cancer: how have recent advances in molecular markers and imaging enhanced our ability to prognosticate risk?","year":2003,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Prostate cancer; Oncology; Prostate; Cancer; Internal medicine; Gynecology","score_opus":0.044790958423923326,"score_gpt":0.4334559548225279,"score_spread":0.3886649963986046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017801391","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008528153,0.9832969,0.000007341511,0.00218284,0.0002717728,0.0050383066,0.00009769354,0.000012298595,0.00056471187],"genre_scores_gemma":[0.00077588286,0.9958526,0.0012574248,0.00008349324,0.000023106082,0.0017891196,0.000057122437,0.00004405915,0.00011720312],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99675053,0.0009667206,0.0006169516,0.00078118587,0.00028013688,0.0006044793],"domain_scores_gemma":[0.99816936,0.0007384235,0.00038229444,0.00031465097,0.0001803465,0.00021494672],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00096985867,0.00042202376,0.0020305961,0.00037491438,0.000035416408,0.000010364959,0.00015545002,0.00027387563,0.000023322145],"category_scores_gemma":[0.00084291806,0.0003215281,0.0001293839,0.0006426443,0.00044636225,0.00006580884,0.00008921325,0.000810566,0.0000013098413],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038224522,0.00032868626,0.00864565,0.0029728904,0.00013747794,0.00037836016,0.00059801876,0.0000016242523,0.000041244042,0.0000039991355,0.0001828014,0.9828868],"study_design_scores_gemma":[0.007931957,0.0026241236,0.0003824983,0.011734367,0.00024321374,0.000028191758,0.0011384002,0.000008521126,0.00064419606,0.00007314967,0.9748415,0.0003498788],"about_ca_topic_score_codex":0.000083369276,"about_ca_topic_score_gemma":0.00018187349,"teacher_disagreement_score":0.9825369,"about_ca_system_score_codex":0.0016334904,"about_ca_system_score_gemma":0.0019521177,"threshold_uncertainty_score":0.9999237},"labels":[],"label_agreement":null},{"id":"W2022141581","doi":"10.1053/j.seminoncol.2004.01.007","title":"Anti-insulin-like growth factor strategies in breast cancer","year":2004,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Breast cancer; Insulin-like growth factor-binding protein; Insulin-like growth factor; Growth factor; Cancer research; Endocrinology; Internal medicine; Cancer; Receptor; Mammary gland; Oncology","score_opus":0.033445092926653076,"score_gpt":0.36105570669583,"score_spread":0.3276106137691769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022141581","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0045884987,0.98736334,0.0000034399839,0.00048390482,0.0016687817,0.0017042584,0.0003056946,0.0001101025,0.0037720012],"genre_scores_gemma":[0.005485689,0.99236757,0.0002366557,0.00035745557,0.00045016975,0.00039627764,0.0002581501,0.00017452321,0.00027353902],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948549,0.00036566387,0.0018854404,0.001190692,0.0004619286,0.0012413547],"domain_scores_gemma":[0.9977637,0.00042827564,0.0006405698,0.0006535914,0.00016160881,0.00035224154],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00043674617,0.001092807,0.0052073724,0.0015571619,0.00006403966,0.0000402407,0.00057201687,0.0021672999,0.00039083825],"category_scores_gemma":[0.00011908861,0.0009186891,0.0006164428,0.0017041931,0.0003572587,0.00027086076,0.00021505897,0.0025727958,0.00016682454],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00020256967,0.0014184911,0.0070828046,0.026623325,0.0003201967,0.0040456094,0.0011084729,0.0000039390934,0.00002164517,0.0005157446,0.0024416854,0.9562155],"study_design_scores_gemma":[0.003475521,0.0008503929,0.010165701,0.0495621,0.00075772614,0.001754292,0.0005426148,0.0000031362817,0.000007657109,0.00034571582,0.93133515,0.0011999715],"about_ca_topic_score_codex":0.001417491,"about_ca_topic_score_gemma":0.0003697006,"teacher_disagreement_score":0.95501554,"about_ca_system_score_codex":0.0038617502,"about_ca_system_score_gemma":0.0070962724,"threshold_uncertainty_score":0.9999623},"labels":[],"label_agreement":null},{"id":"W2024032952","doi":"10.1016/s0093-7754(03)00228-8","title":"Critical issues in the clinical testing of cancer vaccines: summary of a panel discussion at a symposium entitled ?cancer vaccines: are they here yet?? conducted in Toronto, Canada, December 2002","year":2003,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Clinical trial; Clinical endpoint; Population; Surrogate endpoint; Cancer; Intensive care medicine; Randomized controlled trial; Vaccine efficacy; Adjuvant; Cancer vaccine; Clinical study design; Vaccination; Oncology; Immunology; Internal medicine; Immunotherapy","score_opus":0.03454154447542431,"score_gpt":0.3639646830667037,"score_spread":0.3294231385912794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024032952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9118818,0.08275937,3.5271984e-7,0.0022105135,0.0011254707,0.00040438733,0.000050822844,0.000008392194,0.0015588726],"genre_scores_gemma":[0.9829752,0.013003223,0.00006548637,0.00036688853,0.00002576283,0.00014728565,0.000014809389,0.000024933335,0.003376414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99560213,0.0022934272,0.0011526692,0.0003664777,0.000074479256,0.00051080785],"domain_scores_gemma":[0.9957573,0.0033624172,0.00034137355,0.00037769586,0.00014146432,0.000019796726],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010884216,0.0002532106,0.00091235404,0.00010518176,0.00007092668,0.000004202659,0.00038234744,0.0005178105,0.0028314767],"category_scores_gemma":[0.0016185197,0.00015984382,0.000090718866,0.00028688725,0.00022332076,0.00009946124,0.000099269346,0.0005196136,0.0000050986296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033639567,0.0013506924,0.7856296,0.0001540753,0.00015486105,0.00011305217,0.0040679574,0.000039229795,0.17735665,0.00015132212,0.019420179,0.008198425],"study_design_scores_gemma":[0.014339358,0.002080366,0.67392,0.0046123117,0.00020391447,0.0002802924,0.048860576,0.000038678972,0.054183163,0.0002772689,0.2002463,0.00095781917],"about_ca_topic_score_codex":0.36115178,"about_ca_topic_score_gemma":0.91197824,"teacher_disagreement_score":0.55082643,"about_ca_system_score_codex":0.00074855617,"about_ca_system_score_gemma":0.0011729497,"threshold_uncertainty_score":0.9980801},"labels":[],"label_agreement":null},{"id":"W2026309863","doi":"10.1053/j.seminoncol.2013.09.004","title":"Risk-Based Health Care, the Cancer Survivor, the Oncologist, and the Primary Care Physician","year":2013,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Centers for Disease Control and Prevention","keywords":"Survivorship curve; Medicine; Psychological intervention; Health care; Family medicine; Cancer survivorship; Quality of life (healthcare); Cancer survivor; Population; Cancer; MEDLINE; Intervention (counseling); Nursing; Environmental health; Internal medicine","score_opus":0.03204789974542294,"score_gpt":0.3751807080466998,"score_spread":0.34313280830127685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026309863","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011395399,0.97672117,0.0000041480766,0.0052715284,0.001961825,0.004696931,0.00024882017,0.000043734806,0.010937889],"genre_scores_gemma":[0.00024009017,0.98290795,0.000042110725,0.011786274,0.0009322477,0.0032717655,0.00029664836,0.00008532319,0.0004375935],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99415004,0.0031791371,0.0008452727,0.0007283178,0.00040158478,0.00069565745],"domain_scores_gemma":[0.993592,0.0037973793,0.0009997332,0.0012813272,0.00019393292,0.00013557581],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0016952782,0.0006155883,0.0029645052,0.00012822404,0.0004657989,0.000043513006,0.00082999124,0.00061132864,0.000041108055],"category_scores_gemma":[0.00012858557,0.0002613033,0.0005746705,0.0006264428,0.0015849888,0.000029045264,0.00029946855,0.0023068823,0.000019254745],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014424387,0.00004837178,0.00025624543,0.009648419,0.00013851149,0.000023245264,0.007367188,0.000002646076,2.902913e-8,0.00008498197,0.009295627,0.9729905],"study_design_scores_gemma":[0.0015354978,0.00057253387,0.0002104067,0.007516381,0.0011276591,0.000036492394,0.008109584,0.0000040683476,3.1575334e-7,0.000028608403,0.9805982,0.00026022698],"about_ca_topic_score_codex":0.032038648,"about_ca_topic_score_gemma":0.08343614,"teacher_disagreement_score":0.9727303,"about_ca_system_score_codex":0.0037779657,"about_ca_system_score_gemma":0.0062265443,"threshold_uncertainty_score":0.9999948},"labels":[],"label_agreement":null},{"id":"W2029030461","doi":"10.1016/s0093-7754(01)90065-x","title":"Temozolomide for recurrent high-grade glioma","year":2001,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Temozolomide; Medicine; Anaplastic astrocytoma; Oncology; Glioma; Quality of life (healthcare); Internal medicine; Procarbazine; Lomustine; Progression-free survival; Clinical trial; Dacarbazine; Astrocytoma; Surgery; Chemotherapy; Vincristine; Cancer research","score_opus":0.06659751042198406,"score_gpt":0.4115713583895171,"score_spread":0.34497384796753305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029030461","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045321786,0.99268085,0.0000033655976,0.0007189635,0.0013819985,0.0033719914,0.00010022964,0.000051172596,0.0012382079],"genre_scores_gemma":[0.000029656008,0.99322325,0.001865642,0.00012099214,0.0005122366,0.003089323,0.0007104093,0.00009169322,0.00035680563],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99731547,0.00018158133,0.0009547932,0.0007291982,0.00018184529,0.00063709775],"domain_scores_gemma":[0.9974919,0.0012767885,0.0004262125,0.0005427265,0.00005967965,0.00020268044],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038915378,0.0005530131,0.0034014601,0.00069088594,0.000052621675,0.000010482025,0.00021782579,0.0009436128,0.00013533738],"category_scores_gemma":[0.0002814388,0.00042430774,0.0006945609,0.000650709,0.000103460516,0.000023168886,0.000093668365,0.00046822475,0.00010267157],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008487856,0.0017515313,0.00005198216,0.004566989,0.0002594836,0.0022824525,0.000031312517,1.7747536e-7,0.0000015771395,0.00031197479,0.030763002,0.95989466],"study_design_scores_gemma":[0.0028929655,0.0031758249,0.000016552487,0.01660691,0.0020322406,0.0015105301,0.000025026771,0.0000023151724,0.000015833923,0.00024873216,0.9731665,0.0003065325],"about_ca_topic_score_codex":0.000030175728,"about_ca_topic_score_gemma":0.00010591676,"teacher_disagreement_score":0.9595881,"about_ca_system_score_codex":0.0018523576,"about_ca_system_score_gemma":0.00060862687,"threshold_uncertainty_score":0.9998209},"labels":[],"label_agreement":null},{"id":"W2032836693","doi":"10.1053/j.seminoncol.2014.03.009","title":"Pharmacoeconomics of Cancer Therapies: Considerations With the Introduction of Biosimilars","year":2014,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biosimilar; Medicine; Pharmacoeconomics; Innovator; Health care; Risk analysis (engineering); Reimbursement; Product (mathematics); Intensive care medicine; Business","score_opus":0.03854655976674012,"score_gpt":0.4049752124438392,"score_spread":0.3664286526770991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032836693","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000074316165,0.9939678,0.000028543556,0.0041261544,0.0007120429,0.00053107337,0.00010384827,0.000007994831,0.00044826767],"genre_scores_gemma":[0.0001328856,0.9980108,0.00078844,0.0004426111,0.0001269368,0.00010848409,0.000029330298,0.000022174578,0.00033830391],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975797,0.0010348014,0.0007837566,0.00033487318,0.000025304063,0.00024159906],"domain_scores_gemma":[0.99703413,0.0016899359,0.0008217755,0.00035121175,0.00008931832,0.000013636962],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000955297,0.00026974778,0.0018724533,0.00019224048,0.00005613933,0.0000034156537,0.0002609872,0.0006985953,0.001123181],"category_scores_gemma":[0.00010993303,0.00015195181,0.0002219146,0.00022964743,0.0011722571,0.000021358695,0.00007067719,0.00063945004,0.0000062344384],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007205743,0.00015764886,0.000027815848,0.0014476901,0.0008917652,0.000002031202,0.00021723013,0.0000052189207,0.00044849713,0.0011561913,0.046151664,0.9494222],"study_design_scores_gemma":[0.00039997435,0.00040194427,0.0000042416227,0.00092731946,0.0009304295,0.000064704625,0.00011701663,0.0000013606609,0.0010717366,0.00012789358,0.99579716,0.00015619407],"about_ca_topic_score_codex":0.00003760195,"about_ca_topic_score_gemma":0.00026869136,"teacher_disagreement_score":0.9496455,"about_ca_system_score_codex":0.00013258377,"about_ca_system_score_gemma":0.000449282,"threshold_uncertainty_score":0.99978995},"labels":[],"label_agreement":null},{"id":"W2033893059","doi":"10.1053/j.seminoncol.2003.12.021","title":"Targeted molecules in small cell lung cancer","year":2004,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Lung cancer; Imatinib mesylate; Cancer research; Tyrosine kinase; Targeted therapy; Cancer; Immunoconjugate; Clinical trial; Imatinib; Immunology; Oncology; Antibody; Pathology; Internal medicine; Receptor; Monoclonal antibody","score_opus":0.04207325589161267,"score_gpt":0.44114568123938175,"score_spread":0.3990724253477691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033893059","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001410728,0.9866596,0.000002906118,0.00036868168,0.0004677715,0.0022758015,0.00004105857,0.00003699674,0.010006103],"genre_scores_gemma":[0.000020377465,0.9944539,0.0010351911,0.00016266068,0.00020904867,0.0017167822,0.000078927216,0.00008706549,0.0022360387],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970811,0.00032987326,0.0007959485,0.0007036683,0.00023847498,0.00085095415],"domain_scores_gemma":[0.99863774,0.00045130044,0.0002544792,0.0004256674,0.0000759834,0.00015481061],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005304706,0.00048088995,0.0029577708,0.00080629444,0.000033496653,0.0000071539407,0.00034528956,0.0007490836,0.00026145586],"category_scores_gemma":[0.0003170177,0.00039950237,0.000281371,0.0009193579,0.00022241934,0.000024068038,0.00031601766,0.0016357523,0.000036339978],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00008117441,0.0004182464,0.0012754085,0.069575444,0.00019798074,0.004250924,0.0007481587,0.000016553424,0.000005067376,0.000029121347,0.006095,0.9173069],"study_design_scores_gemma":[0.0016102891,0.00042262234,0.00009123334,0.05159339,0.0004756425,0.00008314015,0.0000972541,0.000008772173,0.000010933518,0.00004256006,0.94524515,0.0003190142],"about_ca_topic_score_codex":0.001304476,"about_ca_topic_score_gemma":0.0028077099,"teacher_disagreement_score":0.93915015,"about_ca_system_score_codex":0.008765458,"about_ca_system_score_gemma":0.005685846,"threshold_uncertainty_score":0.999951},"labels":[],"label_agreement":null},{"id":"W2034666734","doi":"10.1016/s0093-7754(01)90261-1","title":"Zoledronic acid in the treatment of hypercalcemia of malignancy: Results of the international clinical development program","year":2001,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Zoledronic acid; Medicine; Bisphosphonate; Internal medicine; Clinical trial; Urology; Refractory (planetary science); Randomized controlled trial; Malignancy; Gastroenterology; Surgery; Osteoporosis","score_opus":0.128744099947459,"score_gpt":0.4871120132950055,"score_spread":0.3583679133475465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034666734","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019954696,0.9710477,1.5584817e-7,0.00043918547,0.0005468467,0.003121925,0.000043081316,0.0000061572496,0.004840232],"genre_scores_gemma":[0.003313473,0.9941455,0.001330441,0.00006226983,0.000046040845,0.0005251049,0.00012992967,0.000017233708,0.00042999708],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963697,0.00046739605,0.002266622,0.00031757794,0.00029923985,0.00027944526],"domain_scores_gemma":[0.99763685,0.00074012124,0.0010022842,0.00049546926,0.000070215094,0.00005508167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009455394,0.0002513941,0.001990397,0.00018858512,0.00001581591,0.0000011689735,0.00035791652,0.0005181515,0.000018606535],"category_scores_gemma":[0.00021969988,0.00012584095,0.00037698165,0.00043705472,0.00024077627,0.000010521623,0.000064219406,0.00035153268,0.0000052639775],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004062597,0.006808946,0.010287398,0.0013797841,0.00020142143,0.00013000195,0.0006384403,1.397093e-7,2.305476e-7,0.000016429081,0.0002527765,0.9798782],"study_design_scores_gemma":[0.0044231243,0.0038521793,0.006687091,0.010831368,0.00039573503,0.00019294361,0.00007505776,0.000001524727,0.000017661525,0.000017488097,0.97343147,0.00007436475],"about_ca_topic_score_codex":0.00012775618,"about_ca_topic_score_gemma":0.0006877015,"teacher_disagreement_score":0.9798038,"about_ca_system_score_codex":0.0010650572,"about_ca_system_score_gemma":0.0029848446,"threshold_uncertainty_score":0.52949864},"labels":[],"label_agreement":null},{"id":"W2038873999","doi":"10.1016/s0093-7754(02)70178-4","title":"Epoetin alfa in patients not on chemotherapy – Canadian data","year":2002,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Epoetin alfa; Chemotherapy; Oncology; Internal medicine","score_opus":0.04577747811867397,"score_gpt":0.32015250621143865,"score_spread":0.2743750280927647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038873999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9130577,0.00037523604,1.5042927e-7,0.025447523,0.00026982458,0.00041583367,0.00003467514,0.000015658112,0.060383383],"genre_scores_gemma":[0.98652154,0.0012570873,0.00079758296,0.008142105,0.00006255799,0.000019037587,0.0001943526,0.00002263416,0.0029831054],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988528,0.000057965684,0.00023617025,0.00035281607,0.00012856461,0.000371697],"domain_scores_gemma":[0.9991822,0.00010295279,0.000044520846,0.0005157449,0.000017390674,0.00013717261],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018221616,0.00013349319,0.00029782444,0.00022482449,0.000027199258,0.0000034073366,0.00017302654,0.00019594026,0.0012372036],"category_scores_gemma":[0.00011683137,0.000120896504,0.000022489166,0.00018048604,0.000073819385,0.000025870106,0.000037473124,0.00026289694,0.0002282533],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002617812,0.0021407525,0.40275374,0.00001945435,0.000020965537,0.001067676,0.0012606235,0.000002791475,0.000052839212,0.00005072834,0.11632725,0.4760414],"study_design_scores_gemma":[0.011505783,0.0034530016,0.25073215,0.00037185772,0.000020857378,0.000048136186,0.00034361877,0.00034912335,0.0004396799,0.000040403407,0.7324517,0.00024370168],"about_ca_topic_score_codex":0.011427966,"about_ca_topic_score_gemma":0.045101896,"teacher_disagreement_score":0.61612445,"about_ca_system_score_codex":0.0010045954,"about_ca_system_score_gemma":0.00012528867,"threshold_uncertainty_score":0.9996758},"labels":[],"label_agreement":null},{"id":"W2044362858","doi":"10.1053/j.seminoncol.2009.10.010","title":"Evaluating Temsirolimus Activity in Multiple Tumors: A Review of Clinical Trials","year":2009,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Temsirolimus; Medicine; Mantle cell lymphoma; Clinical trial; Oncology; Lymphoma; Sirolimus; Internal medicine; Cancer research; PI3K/AKT/mTOR pathway; Cancer; Discovery and development of mTOR inhibitors; Signal transduction; Biology","score_opus":0.38308368459419134,"score_gpt":0.596782249862561,"score_spread":0.21369856526836967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044362858","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019052506,0.99452907,0.0000111583295,0.000054289743,0.00064950547,0.0020121888,0.000070108654,0.0000089636505,0.0007594728],"genre_scores_gemma":[0.000278305,0.996271,0.0016387014,0.0003277807,0.0007542165,0.0004022949,0.00016316802,0.0000582739,0.00010624311],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9844744,0.009306425,0.0042975172,0.0010786055,0.00031111,0.00053190143],"domain_scores_gemma":[0.9922335,0.003457486,0.003123798,0.00094304956,0.00012883153,0.000113334914],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.026530184,0.0005293626,0.0066317227,0.00023185705,0.000023545743,0.0000059811546,0.000735795,0.001621571,0.0000515572],"category_scores_gemma":[0.0323372,0.00046985465,0.0011654217,0.00045499194,0.00021276638,0.000004307614,0.00026876808,0.0010998311,0.000009476118],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015832834,0.0003884341,0.0001093851,0.020634655,0.000085424865,0.00005144177,0.000011048502,0.0000060718025,0.0005414711,0.0000015780483,0.0019080144,0.97610414],"study_design_scores_gemma":[0.0012748077,0.0021071292,0.000026571297,0.13551217,0.0003493323,0.000066766144,0.000006001268,0.000024553317,0.00022157536,0.000023200624,0.8599779,0.00040996406],"about_ca_topic_score_codex":0.000043775257,"about_ca_topic_score_gemma":0.00011160626,"teacher_disagreement_score":0.9756942,"about_ca_system_score_codex":0.0003342555,"about_ca_system_score_gemma":0.0029186972,"threshold_uncertainty_score":0.9997753},"labels":[],"label_agreement":null},{"id":"W2045470396","doi":"10.1053/j.seminoncol.2012.09.004","title":"Selective T-Cell Depletion for Haplotype-Mismatched Allogeneic Stem Cell Transplantation","year":2012,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"","keywords":"Medicine; Transplantation; Stem cell; Haplotype; Cell; Immunology; Cancer research; Genetics; Internal medicine; Gene; Biology; Genotype","score_opus":0.05291611413076512,"score_gpt":0.35306248216744235,"score_spread":0.3001463680366772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045470396","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006660372,0.98532134,0.0023815841,0.000044102668,0.0007472393,0.004754335,0.000100223864,0.00009391127,0.0058912397],"genre_scores_gemma":[0.0012958494,0.98940694,0.004501487,0.00008429444,0.000264111,0.0013817506,0.0015298914,0.00016153569,0.0013741119],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967839,0.00044931824,0.0011580018,0.00067333813,0.000260944,0.0006744732],"domain_scores_gemma":[0.99742854,0.0013583341,0.0005632868,0.00034065024,0.000115126255,0.00019406287],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0009005259,0.00056810677,0.00230188,0.00049510424,0.00006336695,0.000009147227,0.00018928615,0.0014648846,0.000060680475],"category_scores_gemma":[0.000013129553,0.000530489,0.00045072706,0.00042885146,0.000070720824,0.00006832572,0.000013945983,0.0006236012,0.00016292505],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048373084,0.0008636913,0.00024478757,0.13961639,0.00014140396,0.00017766411,0.0032660007,0.000003863272,0.00072636583,0.00004754279,0.0005263205,0.8539022],"study_design_scores_gemma":[0.0038614771,0.0014694323,0.00005997243,0.014250228,0.0069793444,0.0013175064,0.00033208675,0.00001858439,0.0026815464,0.000042296993,0.9682571,0.0007304012],"about_ca_topic_score_codex":0.000018778834,"about_ca_topic_score_gemma":0.000054308533,"teacher_disagreement_score":0.9677308,"about_ca_system_score_codex":0.001083811,"about_ca_system_score_gemma":0.0009181173,"threshold_uncertainty_score":0.99983144},"labels":[],"label_agreement":null},{"id":"W2051674705","doi":"10.1053/sonc.2002.32904","title":"Doctor's dilemma: Incorporating tumor markers into clinical decision-making","year":2002,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Dilemma; Clinical decision making; Intensive care medicine; Oncology; Medical physics; Epistemology","score_opus":0.04443460594989301,"score_gpt":0.42330899374947184,"score_spread":0.3788743877995788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051674705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9723898,0.0021856632,0.0000417735,0.002146504,0.00072973873,0.00051215483,0.000002639943,0.000052067866,0.021939656],"genre_scores_gemma":[0.98051584,0.0009281724,0.016375711,0.00073537516,0.0003392193,0.00006908916,0.000008271869,0.000026920094,0.0010013729],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99801,0.00020868472,0.0006432979,0.0004313511,0.00028133774,0.00042534465],"domain_scores_gemma":[0.99746364,0.0018144891,0.00014604231,0.00030809813,0.000088697336,0.00017903483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011024997,0.0001649851,0.0005306694,0.00024508237,0.00009524408,0.000014692449,0.00016349542,0.00021487076,0.00086497597],"category_scores_gemma":[0.0015180034,0.00013244482,0.00011458031,0.000423198,0.00033493692,0.00008306143,0.00017527421,0.0006325989,0.00018561818],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012227633,0.00060129224,0.34676275,0.000039843035,0.000048833834,0.0045071086,0.00042063458,0.0000058752253,0.00011994713,0.00011225387,0.022311464,0.62384725],"study_design_scores_gemma":[0.03495219,0.021909472,0.2414316,0.0070563448,0.00034300008,0.0023018653,0.00390784,0.016460422,0.0005349596,0.021113394,0.64851964,0.0014692917],"about_ca_topic_score_codex":0.0000364139,"about_ca_topic_score_gemma":0.00011063293,"teacher_disagreement_score":0.6262082,"about_ca_system_score_codex":0.0007879951,"about_ca_system_score_gemma":0.00022567253,"threshold_uncertainty_score":0.94708806},"labels":[],"label_agreement":null},{"id":"W2051864325","doi":"10.1053/j.seminoncol.2009.07.008","title":"Colorectal Cancer in Young Adults","year":2009,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Disease; Colorectal cancer; Etiology; Population; Young adult; Stage (stratigraphy); Cancer; Presentation (obstetrics); Oncology; Internal medicine; Pediatrics; Gerontology; Intensive care medicine; Surgery","score_opus":0.02743801909510224,"score_gpt":0.39453083839613046,"score_spread":0.3670928193010282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051864325","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021212893,0.9644734,5.3046783e-8,0.0001834726,0.00072077,0.0015112037,0.000044214863,0.00002853056,0.030917061],"genre_scores_gemma":[0.0007357951,0.99655676,0.0000848035,0.00008124181,0.00024301664,0.0011080055,0.00005998237,0.00003825428,0.0010921292],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978869,0.00014152152,0.00070310506,0.00058527186,0.00016822616,0.000514965],"domain_scores_gemma":[0.9992078,0.00024492276,0.00022733628,0.0001872108,0.000043491546,0.000089220084],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020098734,0.00044782364,0.0030569062,0.00044835062,0.000034021636,0.000005192066,0.00013954683,0.0006343017,0.00018980962],"category_scores_gemma":[0.000100782956,0.00034744316,0.00028714043,0.00063241855,0.000112910035,0.000026534113,0.00009005855,0.0007397318,0.000027042055],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039956486,0.0004334391,0.0030282142,0.0022011725,0.00012012509,0.0014847147,0.0006562682,3.2171374e-7,2.0125134e-7,0.000009470737,0.0011887404,0.99047774],"study_design_scores_gemma":[0.0019210917,0.0023550089,0.004663502,0.032889806,0.0005387871,0.0004256787,0.00015938928,0.0000035186222,7.4782685e-7,0.00002067318,0.95672274,0.00029906924],"about_ca_topic_score_codex":0.0009219306,"about_ca_topic_score_gemma":0.026962077,"teacher_disagreement_score":0.9901787,"about_ca_system_score_codex":0.004076502,"about_ca_system_score_gemma":0.0010994313,"threshold_uncertainty_score":0.9998978},"labels":[],"label_agreement":null},{"id":"W2053652371","doi":"10.1053/j.seminoncol.2013.12.008","title":"Genes and Pathology of Non-Small Cell Lung Carcinoma","year":2013,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Lung cancer; Adenocarcinoma; Context (archaeology); Histopathology; Pathology; Molecular pathology; Carcinoma; Lung; Pathological; Oncology; Cancer; Internal medicine; Bioinformatics; Gene; Biology; Genetics","score_opus":0.027016335082217544,"score_gpt":0.38322859187598013,"score_spread":0.35621225679376256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053652371","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0072928313,0.9812167,0.0000066151133,0.000046081976,0.00030030985,0.0013587336,0.000029040282,0.000008103607,0.009741527],"genre_scores_gemma":[0.0002805126,0.9939222,0.002773828,0.00005598661,0.00009199613,0.00041318478,0.00011028084,0.000036031604,0.0023159902],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987423,0.00010590896,0.00050386996,0.00034566235,0.00005833317,0.0002439167],"domain_scores_gemma":[0.99905235,0.00024077311,0.00029230458,0.00027461772,0.000053969772,0.00008599315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012228865,0.00025233542,0.0017437066,0.00027633065,0.000022312352,0.0000027465842,0.00008825538,0.0005214108,0.00007893079],"category_scores_gemma":[0.000021103631,0.00019132618,0.00014215075,0.0001539368,0.00014023135,0.00001620964,0.00008459468,0.0002600145,0.000016267051],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000073336128,0.00019913269,0.0027009856,0.011688291,0.00008274519,0.00055242947,0.00053570315,1.2641515e-7,0.000021151915,0.000014894752,0.0012034306,0.9829938],"study_design_scores_gemma":[0.0011481855,0.000962037,0.0005118963,0.004140984,0.0024551253,0.00079010765,0.00018556709,0.000007375249,0.00001914106,0.000015878382,0.9895988,0.00016491264],"about_ca_topic_score_codex":0.0001116376,"about_ca_topic_score_gemma":0.000029250015,"teacher_disagreement_score":0.98839533,"about_ca_system_score_codex":0.0003700152,"about_ca_system_score_gemma":0.00090643455,"threshold_uncertainty_score":0.78020555},"labels":[],"label_agreement":null},{"id":"W2054571776","doi":"10.1053/sonc.2002.37470","title":"Pemetrexed in the treatment of non[ndash ]small cell lung cancer","year":2002,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Pemetrexed; Medicine; Docetaxel; Oncology; Internal medicine; Lung cancer; Chemotherapy; Carboplatin; Regimen; Rash; Cisplatin","score_opus":0.04361158469312567,"score_gpt":0.4382746969562653,"score_spread":0.39466311226313966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054571776","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00089410844,0.9741263,0.0000011587975,0.00018503684,0.00035400444,0.0024390228,0.00006897546,0.000007881031,0.021923538],"genre_scores_gemma":[0.000119024975,0.9914784,0.0003444608,0.00009475236,0.00015468914,0.0017625869,0.0001254586,0.0000369577,0.0058837086],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99833435,0.00018820593,0.00064839213,0.00036556367,0.00013991022,0.0003235718],"domain_scores_gemma":[0.9987047,0.00046050086,0.00032609946,0.00041682943,0.00003628891,0.000055636156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015069901,0.00034126977,0.0018589484,0.00038536923,0.000025903593,0.0000039149104,0.00017381359,0.00037686198,0.00029864238],"category_scores_gemma":[0.000016093492,0.00020170126,0.00032591654,0.0005913766,0.00007956641,0.0000148331255,0.00001922703,0.00025840817,0.000014232138],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018422641,0.0021599745,0.0013524384,0.0038455694,0.00021023759,0.0005001206,0.003853195,0.0000028927063,5.925864e-7,0.000005749959,0.0024044144,0.98564637],"study_design_scores_gemma":[0.0022918517,0.0017258793,0.00028112732,0.007052137,0.003325061,0.00006763281,0.0002821504,0.000017955357,0.0000031693,0.0000034025247,0.9848056,0.00014405309],"about_ca_topic_score_codex":0.00075540505,"about_ca_topic_score_gemma":0.0011012058,"teacher_disagreement_score":0.98550236,"about_ca_system_score_codex":0.0028658132,"about_ca_system_score_gemma":0.0010018261,"threshold_uncertainty_score":0.8225139},"labels":[],"label_agreement":null},{"id":"W2056080086","doi":"10.1053/sonc.2003.50061","title":"The malignant clone in Waldenstrom's macroglobulinemia","year":2003,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"clone (Java method); Waldenstrom macroglobulinemia; Macroglobulinemia; Immunoglobulin D; Immunology; Bone marrow; Medicine; Immunoglobulin M; Antibody; Immunoglobulin gene; CD20; Biology; Pathology; B cell; Immunoglobulin G; Multiple myeloma; Lymphoma; Genetics; Gene","score_opus":0.01666658269212918,"score_gpt":0.3431467620100544,"score_spread":0.3264801793179252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056080086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94106394,0.0039192787,0.000009309424,0.0032776394,0.00040510733,0.0006332243,0.0000019339693,0.000025215419,0.05066432],"genre_scores_gemma":[0.98837626,0.0031363934,0.0015123056,0.0005583003,0.00009208929,0.00011430503,0.0000062838735,0.00002948363,0.006174561],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977206,0.0003021194,0.00048728305,0.0003596311,0.00031926585,0.00081107375],"domain_scores_gemma":[0.998299,0.00092915917,0.00006938248,0.0005034554,0.000057887588,0.00014114044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001577926,0.00016013328,0.00041063328,0.00016211657,0.000067205256,0.000011869487,0.00022579488,0.00028457821,0.00019597397],"category_scores_gemma":[0.0012164677,0.000113615126,0.0000649054,0.0005300002,0.00035760846,0.000028637507,0.000099361256,0.0006034399,0.00013348361],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0071062353,0.0038086546,0.13696736,0.00056408875,0.00026646056,0.07845056,0.0065341336,0.00041027993,0.048602883,0.045483828,0.13237421,0.5394313],"study_design_scores_gemma":[0.057569668,0.0034417487,0.0074252123,0.0008472082,0.000060578437,0.012310158,0.0038880971,0.0043470985,0.01823695,0.004791457,0.8865211,0.0005607127],"about_ca_topic_score_codex":0.00036713478,"about_ca_topic_score_gemma":0.000997896,"teacher_disagreement_score":0.7541469,"about_ca_system_score_codex":0.018062957,"about_ca_system_score_gemma":0.006610714,"threshold_uncertainty_score":0.9990209},"labels":[],"label_agreement":null},{"id":"W2059936546","doi":"10.1053/j.seminoncol.2013.09.009","title":"Renal and Pulmonary Late Effects of Cancer Therapy","year":2013,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Intensive care medicine; Cancer; Chemotherapy; Disease; Radiation therapy; Hematopoietic stem cell transplantation; Epidemiology; Pulmonary toxicity; Kidney disease; Natural history; Pathogenesis; Transplantation; Oncology; Toxicity; Internal medicine; Immunology","score_opus":0.010838255025779396,"score_gpt":0.32742886632410473,"score_spread":0.31659061129832533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059936546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869103,0.0059668417,0.000006535708,0.0016232166,0.00010687233,0.0005614815,0.0000011617154,0.0000116321135,0.0048119887],"genre_scores_gemma":[0.98595554,0.009942214,0.00076150376,0.0006171271,0.000085319916,0.00020152038,0.0000032195185,0.000017525,0.0024160636],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991434,0.00008131133,0.0001852662,0.0001856345,0.00014490777,0.00025944714],"domain_scores_gemma":[0.9989912,0.00064546627,0.00005425927,0.00015155075,0.0000619124,0.000095604155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015423699,0.00009260114,0.00032200242,0.0001328888,0.000015340143,0.000002436188,0.000074500334,0.0001733811,0.00023790283],"category_scores_gemma":[0.0001301044,0.00007119674,0.000025497542,0.00016332249,0.00023427427,0.000038856724,0.00006985989,0.00020713468,0.000017281069],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060076284,0.0003113962,0.089500904,0.00021681446,0.00007273114,0.0007807659,0.0006843305,0.0000050454005,0.31323016,0.000036172987,0.007203689,0.5873572],"study_design_scores_gemma":[0.01731976,0.0068147215,0.7839393,0.0017001982,0.000085529355,0.00068402133,0.00028953722,0.007140971,0.13870205,0.0023203387,0.04061921,0.00038436073],"about_ca_topic_score_codex":0.00091991137,"about_ca_topic_score_gemma":0.000030261286,"teacher_disagreement_score":0.6944384,"about_ca_system_score_codex":0.00039806767,"about_ca_system_score_gemma":0.00039427853,"threshold_uncertainty_score":0.29033187},"labels":[],"label_agreement":null},{"id":"W2062119453","doi":"10.1053/j.seminoncol.2013.01.001","title":"Exercise Therapy as Treatment for Cardiovascular and Oncologic Disease After a Diagnosis of Early-Stage Cancer","year":2013,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia, Okanagan Campus; University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Cancer; Disease; Adjuvant therapy; Stage (stratigraphy); Internal medicine; Intensive care medicine; Oncology","score_opus":0.07458153917372895,"score_gpt":0.3985226177539175,"score_spread":0.32394107858018856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062119453","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.052193865,0.9410105,0.0000031709726,0.00010063256,0.00019922848,0.0061763353,0.00015566756,0.000019267865,0.00014134159],"genre_scores_gemma":[0.0015833187,0.97363204,0.000339159,0.00013364344,0.00020826001,0.023093717,0.00008059954,0.000065100605,0.00086418714],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981761,0.0001958117,0.0005403729,0.0005763207,0.00018241593,0.0003289766],"domain_scores_gemma":[0.9985252,0.00044188875,0.00025266196,0.000491606,0.0000828666,0.00020578751],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029790858,0.0004392882,0.003145748,0.0002430376,0.000031351534,0.000008858874,0.000096241565,0.00067134487,0.00016867906],"category_scores_gemma":[0.00006486791,0.00032521941,0.0015222204,0.00019350498,0.00017909668,0.00004531731,0.000035507946,0.0002183142,0.0000061153905],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005639485,0.00044774116,0.0005414912,0.005139186,0.0011399696,0.00017603172,0.00042344249,0.0000012576783,0.000008478295,0.000007376619,0.00015152805,0.9913995],"study_design_scores_gemma":[0.0031397103,0.0023775776,0.00020245313,0.012590441,0.0033109614,0.000027108053,0.000058531656,0.0000014138969,0.0003362531,0.00006843283,0.9776096,0.00027754973],"about_ca_topic_score_codex":0.00049500796,"about_ca_topic_score_gemma":0.00003821164,"teacher_disagreement_score":0.991122,"about_ca_system_score_codex":0.0011357876,"about_ca_system_score_gemma":0.0009955274,"threshold_uncertainty_score":0.99992},"labels":[],"label_agreement":null},{"id":"W2063044382","doi":"10.1053/sonc.2002.37418","title":"Treatment of bone complications in advanced prostate cancer: Rationale for bisphosphonate use and results of a phase III trial with zoledronic acid","year":2002,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Zoledronic acid; Medicine; Prostate cancer; Bisphosphonate; Bone pain; Bone disease; Cancer; Internal medicine; Oncology; Surgery; Urology; Osteoporosis","score_opus":0.08148374553096663,"score_gpt":0.4323332133059353,"score_spread":0.3508494677749687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063044382","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02701567,0.9613025,0.0000022410436,0.00030260134,0.000081300066,0.010094728,0.0011157483,0.000007584836,0.00007758404],"genre_scores_gemma":[0.0020495846,0.98790747,0.0024237977,0.000019181969,0.000010921458,0.005926088,0.0008236707,0.000027566271,0.00081173785],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978276,0.00008988909,0.0013166316,0.00039347933,0.00010362804,0.00026876174],"domain_scores_gemma":[0.99797386,0.0006004667,0.00094895065,0.00027657143,0.00010003849,0.0001000995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014686777,0.00026258687,0.002303587,0.0002880826,0.000028021826,0.0000019353297,0.000037947248,0.00022581063,0.000006197166],"category_scores_gemma":[0.000093922725,0.00019136857,0.00011153322,0.00032446405,0.00014054251,0.00004176169,0.000012940118,0.00012603085,5.9541014e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.060425058,0.0042636306,0.00011369895,0.0029650454,0.00014801188,0.00006332261,0.000578611,0.0000029143073,0.0000036825243,0.000022104461,0.000089202025,0.9313247],"study_design_scores_gemma":[0.28287393,0.020238232,0.000052619573,0.0073404326,0.0007392397,0.000102954,0.000034120683,0.00003683166,0.000027754031,0.0000135114915,0.6884136,0.00012673734],"about_ca_topic_score_codex":0.00066568295,"about_ca_topic_score_gemma":0.0026246253,"teacher_disagreement_score":0.931198,"about_ca_system_score_codex":0.0009800257,"about_ca_system_score_gemma":0.001435972,"threshold_uncertainty_score":0.78037834},"labels":[],"label_agreement":null},{"id":"W2065876746","doi":"10.1053/j.seminoncol.2003.11.036","title":"New frontiers in the treatment of malignant glioma","year":2003,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Loss of heterozygosity; Glioma; CDKN2A; Radiation therapy; Oncology; Chemotherapy; Oligodendroglioma; Neurosurgery; Targeted therapy; Internal medicine; Bioinformatics; Cancer research; Astrocytoma; Gene; Cancer; Surgery; Biology; Genetics; Allele","score_opus":0.04241988482452763,"score_gpt":0.36986062256930724,"score_spread":0.3274407377447796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065876746","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007655149,0.99380046,0.000002859517,0.00025547534,0.0005915941,0.001906781,0.000015754622,0.0000062419435,0.0026553387],"genre_scores_gemma":[0.00002642112,0.99683666,0.0021089555,0.000063502615,0.00007968286,0.0005049678,0.00007017639,0.000032705517,0.00027692513],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99787474,0.0003913105,0.00078141957,0.00040348645,0.00018303485,0.00036604],"domain_scores_gemma":[0.9986224,0.0004153084,0.00031157897,0.000540679,0.000018307872,0.00009168895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002763646,0.00039575086,0.002761086,0.0006181999,0.000016778682,0.000004596589,0.00017945083,0.00049093115,0.000081795],"category_scores_gemma":[0.000035807683,0.00021855583,0.00047504203,0.000747861,0.00007660214,0.000013085521,0.00001560796,0.00018222914,0.000017332608],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032081814,0.002509684,0.0011257149,0.0009609637,0.00022086341,0.0041564954,0.0005351563,2.964263e-7,6.665426e-7,0.00009300148,0.016116817,0.97424823],"study_design_scores_gemma":[0.0023901225,0.0034091799,0.00008622589,0.0063284803,0.0013411826,0.00072486553,0.00026426997,5.0480935e-7,0.00001632934,0.00008723039,0.9852092,0.00014238365],"about_ca_topic_score_codex":0.00015298896,"about_ca_topic_score_gemma":0.000104734114,"teacher_disagreement_score":0.9741059,"about_ca_system_score_codex":0.0014753717,"about_ca_system_score_gemma":0.0008692106,"threshold_uncertainty_score":0.89124477},"labels":[],"label_agreement":null},{"id":"W2070471476","doi":"10.1053/j.seminoncol.2005.07.008","title":"Epigenetic Therapy of Cancer With 5-Aza-2′-Deoxycytidine (decitabine)","year":2005,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":197,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Decitabine; Azacitidine; Cancer research; DNA methylation; Medicine; Leukemia; Cancer; Epigenetics; Epigenetic therapy; Pharmacology; Biology; Immunology; Internal medicine; Genetics; Gene; Gene expression","score_opus":0.04006985032835864,"score_gpt":0.39938058844296526,"score_spread":0.3593107381146066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070471476","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0056672944,0.9920201,0.00006447668,0.000038156082,0.00022483163,0.0006869243,0.000048664555,0.0000061472692,0.00124342],"genre_scores_gemma":[0.00065725663,0.99623376,0.0015339907,0.000039216433,0.00045474665,0.00026291577,0.0002274817,0.00008417935,0.00050645554],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978354,0.00026499442,0.0007516648,0.00060308544,0.00016812194,0.0003767581],"domain_scores_gemma":[0.9985846,0.00010458101,0.0005660763,0.0005543258,0.00010853705,0.0000818722],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038668836,0.00042905018,0.0013404104,0.00021618775,0.000029337187,0.0000064075093,0.00038302332,0.00084160274,0.00008590716],"category_scores_gemma":[0.00005443333,0.00033901166,0.00023217981,0.00031794695,0.00018168289,0.000002053838,0.00010744782,0.00028516122,0.0000059495324],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007486505,0.0001678824,0.00024831216,0.00045307254,0.00012898486,0.000010674609,0.00004001888,0.0000792459,0.0013292297,0.0000094699,0.000140349,0.9973179],"study_design_scores_gemma":[0.00067094923,0.0013638154,0.000069058384,0.0017197089,0.0001071646,0.000012159568,0.000013578407,0.0000029209612,0.0038826254,0.000022543762,0.9917728,0.0003626858],"about_ca_topic_score_codex":0.000060394206,"about_ca_topic_score_gemma":0.00053741975,"teacher_disagreement_score":0.9969552,"about_ca_system_score_codex":0.0001455574,"about_ca_system_score_gemma":0.0008758715,"threshold_uncertainty_score":0.9999062},"labels":[],"label_agreement":null},{"id":"W2072311991","doi":"10.1053/j.seminoncol.2003.08.020","title":"Erythropoietin as a critical component of breast cancer therapy: survival, synergistic, and cognitive applications","year":2003,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Erythropoietin; Medicine; Epoetin alfa; Hypoxia (environmental); Angiogenesis; Vascular endothelial growth factor; Breast cancer; Internal medicine; Cancer; Oncology; Cancer research; VEGF receptors","score_opus":0.048723937167649375,"score_gpt":0.432361008081544,"score_spread":0.3836370709138946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072311991","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014630864,0.9893934,0.000022513743,0.0010851152,0.00022937144,0.0016346454,0.00029663346,0.000021430553,0.0071705617],"genre_scores_gemma":[0.0004963392,0.99657357,0.000561028,0.00020024033,0.00014370511,0.0012729301,0.00015856516,0.000060350387,0.00053325313],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976962,0.00040524246,0.0007384393,0.0005777599,0.00021593174,0.000366376],"domain_scores_gemma":[0.9972813,0.001804937,0.00026732608,0.00028150232,0.00017352219,0.00019140632],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003142326,0.00042930685,0.0024515025,0.00020955804,0.00006405376,0.0000065713984,0.000098963385,0.0005750799,0.0007305998],"category_scores_gemma":[0.00011572754,0.0003387488,0.00023183135,0.00031125362,0.0011020337,0.000015367103,0.000070922855,0.00055611646,0.000032503965],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011826751,0.0018048497,0.0002515497,0.006808524,0.0003168485,0.00027595574,0.00014273897,3.93877e-8,0.000008078178,0.0013165507,0.0009429702,0.9880136],"study_design_scores_gemma":[0.0017550333,0.00090024044,0.00009112917,0.020256124,0.0016628457,0.0014965627,0.0005835085,8.3659455e-7,0.00000879543,0.00012951058,0.97281307,0.00030235288],"about_ca_topic_score_codex":0.00021716014,"about_ca_topic_score_gemma":0.000036326714,"teacher_disagreement_score":0.98771125,"about_ca_system_score_codex":0.00042979603,"about_ca_system_score_gemma":0.0010445757,"threshold_uncertainty_score":0.9999065},"labels":[],"label_agreement":null},{"id":"W2072648699","doi":"10.1053/j.seminoncol.2014.04.006","title":"Platelets Effects on Tumor Growth","year":2014,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Intravasation; Platelet; Extravasation; Medicine; Metastasis; Cancer research; Cancer; Cancer cell; Primary tumor; Tumor microenvironment; Tumor cells; Cell biology; Immunology; Pathology; Biology; Internal medicine","score_opus":0.020486402201631504,"score_gpt":0.3599807626362805,"score_spread":0.339494360434649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072648699","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042623104,0.97241575,0.0000012983126,0.00012527648,0.0014495536,0.0024142512,0.000013222281,0.00012303032,0.023031382],"genre_scores_gemma":[0.00007329103,0.9956462,0.00069542415,0.0011876848,0.00071929715,0.0010337384,0.0001284313,0.00014743202,0.0003685343],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99632466,0.00081362994,0.0009673429,0.00084740436,0.00034693867,0.00070003944],"domain_scores_gemma":[0.99593455,0.0024606017,0.0005179593,0.0007183143,0.000067531495,0.0003010579],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009403646,0.00070272613,0.0037918298,0.00083584577,0.00005444373,0.00001129069,0.00040210274,0.001074278,0.00013175137],"category_scores_gemma":[0.0014623762,0.00058284495,0.00065424095,0.0004770029,0.00020375139,0.000026754597,0.00017966318,0.0011739794,0.00095022976],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021071685,0.0002916318,0.00024252142,0.05132918,0.00021849516,0.008157549,0.000030450794,2.3919695e-8,0.0000010281162,0.00018250036,0.019198304,0.9201376],"study_design_scores_gemma":[0.0011737819,0.0014703531,0.00006795915,0.06481424,0.0011410431,0.0010285148,0.0000051626957,0.000002576331,0.000034161243,0.00010998349,0.929719,0.0004332455],"about_ca_topic_score_codex":0.0000033630668,"about_ca_topic_score_gemma":0.000002823144,"teacher_disagreement_score":0.9197044,"about_ca_system_score_codex":0.0014946692,"about_ca_system_score_gemma":0.0009122151,"threshold_uncertainty_score":0.9998276},"labels":[],"label_agreement":null},{"id":"W2073922081","doi":"10.1053/j.seminoncol.2008.12.007","title":"Management of Early and Locally Advanced Cervical Cancer","year":2009,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Cervical cancer; Malignancy; Cancer; Primary treatment; Cervical carcinoma; Oncology; Primary cancer; Internal medicine; Intensive care medicine","score_opus":0.037623921247355,"score_gpt":0.4045031393347371,"score_spread":0.3668792180873821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073922081","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000379346,0.98687345,0.000002467706,0.00013817158,0.00022418873,0.0010897211,0.000020495878,0.000015103451,0.011257038],"genre_scores_gemma":[0.00013807735,0.9967734,0.0014249262,0.00013730326,0.00008843015,0.00025907956,0.000028637389,0.000026585172,0.0011235512],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983114,0.000097723976,0.00065439625,0.00042817814,0.00020454975,0.00030377146],"domain_scores_gemma":[0.9991182,0.00020688273,0.00024809365,0.00024781277,0.000038184175,0.00014082903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016281162,0.00029809482,0.0023096274,0.00027054743,0.0000149099005,0.0000029294526,0.00013416639,0.00042948284,0.00016987225],"category_scores_gemma":[0.00001949165,0.00022358421,0.00020440362,0.0006022106,0.00010642332,0.000021748368,0.000106367865,0.00036860385,0.000010961232],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034071677,0.00032806347,0.00011581893,0.010611373,0.00025160942,0.0007756736,0.000031496074,2.636796e-7,3.036058e-7,0.00015973087,0.000056080862,0.9873289],"study_design_scores_gemma":[0.003187116,0.0026472847,0.0011372901,0.033634022,0.0015269427,0.00007587886,0.000022603404,4.5468835e-7,0.0000015003874,0.00015933202,0.9574287,0.00017890353],"about_ca_topic_score_codex":0.00007838103,"about_ca_topic_score_gemma":0.000038770188,"teacher_disagreement_score":0.98714995,"about_ca_system_score_codex":0.0006527803,"about_ca_system_score_gemma":0.00026092117,"threshold_uncertainty_score":0.91174996},"labels":[],"label_agreement":null},{"id":"W2074340276","doi":"10.1053/sonc.2003.50042","title":"Abnormal expression of hyaluronan synthases in patients with Waldenstrom's macroglobulimenia","year":2003,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Hyaluronan synthase; Extracellular matrix; Hyaluronic acid; Immune system; Multiple myeloma; Waldenstrom macroglobulinemia; Extracellular; Cancer research; Molecular biology; Cell biology; Medicine; Biology; Pathology; Immunology; Lymphoma; Genetics","score_opus":0.005451976096725701,"score_gpt":0.2586122874170537,"score_spread":0.253160311320328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074340276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957498,0.00043253694,0.000037480524,0.000029495217,0.00006030529,0.00033513646,0.000023092882,0.0000032236867,0.0033289609],"genre_scores_gemma":[0.9970044,0.00008669851,0.0025144727,0.000040059298,0.000016079804,0.000056473273,0.000053995154,0.000017529617,0.00021031115],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99855185,0.00020950093,0.00028809774,0.00034918688,0.00018790818,0.00041343132],"domain_scores_gemma":[0.9994291,0.000036768208,0.00009291344,0.0002978698,0.0000692289,0.00007408884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028702503,0.00015460208,0.00025672224,0.0001361322,0.000028093344,0.0000047201042,0.00020605633,0.00022464084,0.00006349139],"category_scores_gemma":[0.00013473608,0.0001329154,0.00003541305,0.00018460871,0.0001859407,0.000006032298,0.00009668803,0.00017873039,0.0000027027181],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018839655,0.0011837356,0.8119005,0.000042613832,0.00001796565,0.00007813275,0.00012160936,0.00016670229,0.1587823,0.00008750975,0.00055635953,0.025178632],"study_design_scores_gemma":[0.0061671347,0.008966389,0.18421514,0.00021774507,0.000009800542,0.000034530025,0.00026121121,0.000010527026,0.77864444,0.000074911986,0.021016741,0.00038141015],"about_ca_topic_score_codex":0.00005676426,"about_ca_topic_score_gemma":0.00024577152,"teacher_disagreement_score":0.6276853,"about_ca_system_score_codex":0.000077989986,"about_ca_system_score_gemma":0.00023076085,"threshold_uncertainty_score":0.5420133},"labels":[],"label_agreement":null},{"id":"W2074609728","doi":"10.1053/j.seminoncol.2007.03.008","title":"Local Management of Adult Soft Tissue Sarcomas","year":2007,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Mount Sinai Hospital","funders":"","keywords":"Medicine; Radiation therapy; Sarcoma; Soft tissue; Adjuvant radiotherapy; Trunk; Surgery; Soft tissue sarcoma; Adjuvant; Adjuvant therapy; Radiology; Oncology; Chemotherapy; Pathology","score_opus":0.04790951265337286,"score_gpt":0.4122803651611181,"score_spread":0.36437085250774526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074609728","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000028936262,0.9769137,0.00007436373,0.00011102432,0.0003305809,0.0014308072,0.000015493239,0.00002431247,0.021070795],"genre_scores_gemma":[0.00009658184,0.9943065,0.0038393363,0.00016192393,0.00008111807,0.0002993644,0.00013769101,0.00005591363,0.0010215804],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997695,0.00012002427,0.000982486,0.00048844493,0.00027108577,0.000442907],"domain_scores_gemma":[0.9983979,0.000530509,0.0003432108,0.00053285126,0.00006470477,0.00013085593],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031602112,0.00040316198,0.002640091,0.00044904766,0.000019318348,0.0000025388883,0.00020373963,0.0006592241,0.00020976874],"category_scores_gemma":[0.000029779054,0.00031946434,0.00034424223,0.00044927828,0.00020805313,0.000014057823,0.00016174682,0.00042007133,0.00016573865],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043867847,0.0016480987,0.00023118558,0.013964614,0.00040388413,0.008446965,0.00005026728,2.6432306e-7,7.460762e-8,0.00083151856,0.002716483,0.97166276],"study_design_scores_gemma":[0.0011790282,0.00097057037,0.000101541904,0.03348721,0.0017869408,0.0007329264,0.00014998413,0.0000012118992,0.000014257925,0.000053798733,0.9613247,0.00019784128],"about_ca_topic_score_codex":0.00005659179,"about_ca_topic_score_gemma":0.00005172102,"teacher_disagreement_score":0.97146493,"about_ca_system_score_codex":0.0011215576,"about_ca_system_score_gemma":0.00023906866,"threshold_uncertainty_score":0.99992573},"labels":[],"label_agreement":null},{"id":"W2078136306","doi":"10.1053/j.seminoncol.2004.07.029","title":"Perspectives on the future of bisphosphonate use in breast cancer patients","year":2004,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Clinical trial; Bisphosphonate; Stage (stratigraphy); Oncology; Disease; Cancer; Adjuvant therapy; Internal medicine; Bone disease; Surgery; Intensive care medicine; Osteoporosis","score_opus":0.026847680153339094,"score_gpt":0.37426792429964384,"score_spread":0.34742024414630474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078136306","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0069863023,0.9892378,1.53726e-8,0.0010700546,0.00052969955,0.0014995874,0.00018438572,0.0000079940555,0.0004841666],"genre_scores_gemma":[0.0016084969,0.9972865,0.00005351893,0.00027066402,0.000045393062,0.00033766576,0.000056183548,0.00003652138,0.00030503812],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998321,0.00020354726,0.00057026633,0.00038052394,0.00018107983,0.00034359656],"domain_scores_gemma":[0.9987963,0.00036723993,0.0003589333,0.00031194283,0.000075862445,0.00008975436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018154227,0.00030183475,0.0015957339,0.00027577567,0.00002642948,0.0000025366348,0.0001261164,0.00054812344,0.00012675475],"category_scores_gemma":[0.000059620827,0.00017681373,0.00018214325,0.0005008756,0.00012924004,0.000026117383,0.000044056163,0.0007981278,0.000018898021],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003178414,0.0019353776,0.016564965,0.0037158614,0.000096951466,0.00021269928,0.0011006196,5.187956e-7,2.1244965e-8,0.00029140708,0.0007359854,0.97502774],"study_design_scores_gemma":[0.0028751737,0.001196117,0.026291484,0.047991633,0.00034664082,0.00010234894,0.00058363465,3.2913601e-7,4.771738e-7,0.000059171358,0.920361,0.00019199096],"about_ca_topic_score_codex":0.002021774,"about_ca_topic_score_gemma":0.0015534437,"teacher_disagreement_score":0.97483575,"about_ca_system_score_codex":0.002790634,"about_ca_system_score_gemma":0.0016291026,"threshold_uncertainty_score":0.7297411},"labels":[],"label_agreement":null},{"id":"W2087324461","doi":"10.1053/j.seminoncol.2014.04.007","title":"Pharmacological Regulation of Platelet Factors That Influence Tumor Angiogenesis","year":2014,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Angiogenesis; Medicine; Platelet; Metastasis; Hemostasis; Cancer research; Neovascularization; Mechanism (biology); Pathological; Cancer; Immunology; Pharmacology; Internal medicine","score_opus":0.03620789227325197,"score_gpt":0.3634344828822936,"score_spread":0.3272265906090416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087324461","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.059337184,0.93927616,0.000029474217,0.000009221298,0.00034138598,0.00047808394,0.00006318471,0.000010130659,0.00045514954],"genre_scores_gemma":[0.01890384,0.9798007,0.0002810485,0.00011322867,0.00017451502,0.00013446511,0.0003325159,0.000050582898,0.00020911604],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99775964,0.0003834461,0.0007054838,0.00061917567,0.00015828361,0.00037399615],"domain_scores_gemma":[0.9985887,0.00019318922,0.0006874963,0.0003746538,0.00006915924,0.00008680808],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043544444,0.00041981615,0.0015164863,0.00018786793,0.000040490944,0.0000062027916,0.000468668,0.0009199822,0.00010506327],"category_scores_gemma":[0.00012353502,0.00034187597,0.00056034006,0.00023642344,0.00023340064,0.0000038831317,0.00021995592,0.00018136967,0.000010847801],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000964524,0.00021586522,0.003233307,0.002605788,0.00034015957,0.00003308881,0.000045634086,0.000066790635,0.0060590715,0.000040903647,0.0044484525,0.9828145],"study_design_scores_gemma":[0.0002497387,0.00046807824,0.0004911546,0.0011117397,0.0002613374,0.000055460667,0.000019966357,0.0000033894705,0.0060921554,0.000013318811,0.99088585,0.0003477973],"about_ca_topic_score_codex":0.000033797645,"about_ca_topic_score_gemma":0.000024721357,"teacher_disagreement_score":0.98643744,"about_ca_system_score_codex":0.00015837286,"about_ca_system_score_gemma":0.0003648822,"threshold_uncertainty_score":0.9999033},"labels":[],"label_agreement":null},{"id":"W2089410776","doi":"10.1016/s0093-7754(01)90035-1","title":"Neovastat, a naturally occurring multifunctional antiangiogenic drug, in phase III clinical trials","year":2001,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Québec Metro High Tech Park (Canada)","funders":"","keywords":"Medicine; Angiogenesis; Vascular endothelial growth factor; In vivo; Lewis lung carcinoma; Pharmacology; Matrigel; Neovascularization; Blood vessel; Thalidomide; Basic fibroblast growth factor; Cancer research; Bone marrow; Matrix metalloproteinase inhibitor; Matrix metalloproteinase; Cancer; Immunology; Internal medicine; Growth factor; Multiple myeloma; Receptor; Biology; VEGF receptors; Metastasis","score_opus":0.24415275304753292,"score_gpt":0.5670275841619712,"score_spread":0.32287483111443827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089410776","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034280878,0.9900725,0.000008198091,0.00011933177,0.0012153425,0.0035492852,0.000110371344,0.00004335872,0.0014535398],"genre_scores_gemma":[0.00023826076,0.99413764,0.0014185115,0.00016810461,0.0008043695,0.00053167704,0.00088207895,0.000070768954,0.001748588],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99054724,0.0034165608,0.003536238,0.0010360944,0.00048495494,0.000978905],"domain_scores_gemma":[0.9905229,0.0074936193,0.000869709,0.00055848283,0.00010233707,0.0004529029],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.007792004,0.00061543094,0.006601638,0.001349673,0.000057873152,0.000018144783,0.00032928414,0.0011325593,0.0007724775],"category_scores_gemma":[0.0060712323,0.000471832,0.0016320397,0.001096451,0.0002475926,0.00007350744,0.00021810754,0.002207405,0.00024266697],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002067945,0.0027497495,0.0018179595,0.0016330375,0.0006974627,0.015738701,0.00007155487,5.548223e-7,0.0000010734394,0.000007192642,0.0048670033,0.97034776],"study_design_scores_gemma":[0.02855702,0.0011804122,0.00014068068,0.012982481,0.0008353468,0.0016783148,0.00007019504,0.00009983643,6.77443e-7,0.000016303655,0.9541194,0.00031936733],"about_ca_topic_score_codex":0.00020069502,"about_ca_topic_score_gemma":0.000474462,"teacher_disagreement_score":0.9700284,"about_ca_system_score_codex":0.0015407195,"about_ca_system_score_gemma":0.0027817881,"threshold_uncertainty_score":0.9997733},"labels":[],"label_agreement":null},{"id":"W2089445137","doi":"10.1053/j.seminoncol.2004.11.013","title":"Palliative radiation therapy","year":2005,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Radiosurgery; Radiation therapy; Palliative care; Cancer; Lung cancer; Population; Disease; Stereotactic radiation therapy; Surgery; Performance status; Oncology; Internal medicine","score_opus":0.09286949844267094,"score_gpt":0.4563326392391604,"score_spread":0.36346314079648945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089445137","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016273481,0.9929328,0.0000039898,0.00039026092,0.00027835142,0.0012973403,0.000025871508,0.000022980545,0.0050321487],"genre_scores_gemma":[0.000004689171,0.9954635,0.0017632297,0.00041287835,0.0004261369,0.00033793933,0.00038886734,0.00004053762,0.0011622359],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984399,0.00032282516,0.0004877093,0.00035533568,0.0001278512,0.00026636937],"domain_scores_gemma":[0.99882776,0.0005053014,0.0002743446,0.00028538052,0.000023348763,0.00008389404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003710922,0.00029968505,0.0017926941,0.0002487722,0.000023849541,0.00000446833,0.00008859771,0.00048968015,0.00043333913],"category_scores_gemma":[0.000073443014,0.00021370368,0.00032552736,0.0002697557,0.00005962768,0.00001946394,0.000025716134,0.00043847103,0.0001719526],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003413158,0.00043427592,0.000047299498,0.0006132713,0.00020828299,0.00035756535,0.00013821233,2.6251666e-7,3.9797477e-8,0.00009841989,0.0032076505,0.9948606],"study_design_scores_gemma":[0.0013860128,0.0011927286,0.00006335504,0.0038136542,0.00043987023,0.00014852219,0.000021804848,0.000001965602,5.127102e-7,0.000035119676,0.99274987,0.00014657684],"about_ca_topic_score_codex":0.000014331546,"about_ca_topic_score_gemma":0.000017825772,"teacher_disagreement_score":0.994714,"about_ca_system_score_codex":0.0012806514,"about_ca_system_score_gemma":0.0006450819,"threshold_uncertainty_score":0.8714583},"labels":[],"label_agreement":null},{"id":"W2089735828","doi":"10.1053/j.seminoncol.2011.01.018","title":"Differential Properties of Current Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors","year":2011,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Novartis Pharmaceuticals Canada","keywords":"Sunitinib; Medicine; Regorafenib; Dasatinib; GiST; Imatinib; Nilotinib; Tyrosine kinase; Sorafenib; Tyrosine-kinase inhibitor; Imatinib mesylate; Pazopanib; Oncology; Internal medicine; Cancer research; Pharmacology; Cancer; Stromal cell; Colorectal cancer; Hepatocellular carcinoma; Receptor","score_opus":0.10511166489116196,"score_gpt":0.3827375051002066,"score_spread":0.2776258402090446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089735828","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037490364,0.9598742,0.0000043307773,0.000025578418,0.00018305882,0.0018858779,0.00003706767,0.0000276598,0.00047185057],"genre_scores_gemma":[0.024888286,0.97294825,0.0011294257,0.000003823894,0.00020865069,0.0004524874,0.00013874217,0.000082910825,0.00014744895],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9962099,0.00042218994,0.0014415269,0.00066234556,0.00035977404,0.00090424414],"domain_scores_gemma":[0.9984244,0.00017211853,0.0005270801,0.00043670135,0.00012294557,0.00031676504],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032917756,0.0006347531,0.0030090301,0.0010606204,0.000026380036,0.000008218227,0.0003012698,0.00016269705,0.00016467486],"category_scores_gemma":[0.000633114,0.00046397006,0.00043962838,0.00052468135,0.00050421304,0.000046659814,0.000309416,0.001497562,0.000038671013],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008764942,0.004727916,0.013638656,0.021665743,0.000050691902,0.005734408,0.000117067684,2.6954325e-7,0.00016964396,0.00010454875,0.0002574103,0.95265716],"study_design_scores_gemma":[0.0071871215,0.0278754,0.0033135354,0.7689464,0.0010374155,0.022724353,0.00031901727,0.000023898952,0.0006271832,0.000069738286,0.16691251,0.0009634077],"about_ca_topic_score_codex":0.00019507279,"about_ca_topic_score_gemma":0.00012652256,"teacher_disagreement_score":0.9516937,"about_ca_system_score_codex":0.0012194671,"about_ca_system_score_gemma":0.0018320924,"threshold_uncertainty_score":0.9997812},"labels":[],"label_agreement":null},{"id":"W2092841476","doi":"10.1053/j.seminoncol.2003.12.015","title":"Antiangiogenic drugs and current strategies for the treatment of lung cancer","year":2004,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Medicine; Lung cancer; Angiogenesis; Cancer; Vascular endothelial growth factor; Chemotherapy; Oncology; Bevacizumab; Clinical trial; Mesothelioma; Cancer research; Immunology; Internal medicine; Pathology; VEGF receptors","score_opus":0.03280033381728383,"score_gpt":0.40697332122602137,"score_spread":0.37417298740873756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092841476","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004206577,0.99772453,0.00008029838,0.000035511242,0.0005244116,0.0009630051,0.00017433506,0.0000025858558,0.00007467949],"genre_scores_gemma":[0.00023320402,0.9979675,0.000117113064,0.0000151628055,0.00035279393,0.0010448805,0.000107243766,0.000032357726,0.00012978697],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99890435,0.00006282285,0.00036551888,0.0003680418,0.000055578992,0.00024367256],"domain_scores_gemma":[0.9992968,0.000115498326,0.00025123847,0.00026302252,0.000039826442,0.0000336273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012807538,0.00027496117,0.0007944614,0.00006277116,0.000047897858,0.00000847884,0.00018178,0.00034706868,0.000011617893],"category_scores_gemma":[0.000007284355,0.00017588297,0.0004256008,0.000093683186,0.00017733323,0.0000016966002,0.000048407648,0.000057186633,3.4069703e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030176769,0.00012688509,0.00004051038,0.0027808691,0.00028683397,0.0000014706625,0.00016760605,0.000014600465,0.000025049958,0.0001174287,0.00087733567,0.99553126],"study_design_scores_gemma":[0.0004495001,0.0006738306,0.0000061958435,0.0021401448,0.00073289237,0.000011575013,0.00011070836,0.000005489919,0.00007945522,0.000036036716,0.9955785,0.00017566787],"about_ca_topic_score_codex":0.00009063786,"about_ca_topic_score_gemma":0.00015709974,"teacher_disagreement_score":0.99535555,"about_ca_system_score_codex":0.00023140897,"about_ca_system_score_gemma":0.0012800877,"threshold_uncertainty_score":0.71722996},"labels":[],"label_agreement":null},{"id":"W2093944201","doi":"10.1053/j.seminoncol.2013.05.011","title":"Selected Toxicities of Targeted Therapies: Presentation and Management","year":2013,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Targeted therapy; Intensive care medicine; Dosing; Toxicity; Renal cell carcinoma; Disease; Radiation therapy; Intervention (counseling); Oncology; Cancer; Internal medicine; Psychiatry","score_opus":0.014273307442966442,"score_gpt":0.2872275127491344,"score_spread":0.27295420530616793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093944201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849231,0.0025009715,0.000011345756,0.00067813945,0.000046890622,0.0007197476,9.818633e-7,0.000015602518,0.011103181],"genre_scores_gemma":[0.99183285,0.0020990183,0.0043554194,0.00011824919,0.00001601074,0.00014250772,0.000017548124,0.000009068557,0.0014093171],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993666,0.000062382605,0.00019527465,0.00013936829,0.00009718056,0.00013923424],"domain_scores_gemma":[0.9996271,0.00009720542,0.000061135,0.00011212668,0.000063899155,0.000038525308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007443686,0.00008099146,0.00022469662,0.00014750128,0.00001256356,0.000003010338,0.000032847354,0.0000701648,0.00020250703],"category_scores_gemma":[0.000020471387,0.00006679927,0.00001839166,0.000171096,0.00008967054,0.00003801305,0.000029119568,0.00006352235,0.000008931899],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091765966,0.0013860943,0.4182305,0.00081617263,0.00061574334,0.000481754,0.016072646,0.00002114474,0.2377288,0.0010466884,0.015710972,0.30697182],"study_design_scores_gemma":[0.0027568922,0.002483425,0.93936306,0.000152247,0.000068759284,0.00008273503,0.0048647355,0.00020744004,0.04639383,0.0008139606,0.0027088209,0.00010411448],"about_ca_topic_score_codex":0.00013942886,"about_ca_topic_score_gemma":0.00002604663,"teacher_disagreement_score":0.5211325,"about_ca_system_score_codex":0.00014434858,"about_ca_system_score_gemma":0.000030377265,"threshold_uncertainty_score":0.27239951},"labels":[],"label_agreement":null},{"id":"W2097235491","doi":"10.1016/s0093-7754(01)90226-x","title":"Extending preclinical models of skeletal manifestations of malignancy to the clinical setting","year":2001,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Osteomalacia; Hypophosphatemia; Malignancy; Prostate cancer; Osteolysis; Calcitriol; Osteopenia; Cancer; Parathyroid hormone; Internal medicine; Oncology; Cancer research; Pathology; Vitamin D and neurology; Osteoporosis; Bone mineral; Surgery; Calcium","score_opus":0.19191769477285311,"score_gpt":0.5339223273840648,"score_spread":0.3420046326112116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097235491","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007781728,0.99021506,0.000083865416,0.0005416013,0.00056699914,0.0020767415,0.00006223545,0.000013420929,0.005661888],"genre_scores_gemma":[0.0005895629,0.9898926,0.008157864,0.00019568492,0.00013952467,0.00021706542,0.00008323272,0.00003815292,0.0006863027],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99577415,0.00070254295,0.002488815,0.00042964428,0.00021102154,0.00039383752],"domain_scores_gemma":[0.994975,0.0033071884,0.0009238769,0.00051211065,0.00008886022,0.00019301283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019093874,0.00025403715,0.0025358,0.00024442375,0.000040896262,0.000001678006,0.0002185374,0.0006616372,0.000047066904],"category_scores_gemma":[0.00095906825,0.0001709052,0.0005013042,0.00047319435,0.00016511836,0.000026857731,0.0001304184,0.0007769322,0.000027839715],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056381035,0.0007324627,0.0011291814,0.0041676774,0.00011713675,0.0004900711,0.00014638684,0.000006588679,3.6430286e-8,0.00021928514,0.0008869846,0.9920478],"study_design_scores_gemma":[0.0012512931,0.002739726,0.00068487634,0.031065982,0.0014780342,0.0014869574,0.000106836334,0.000072227725,1.930616e-7,0.00041679788,0.9605326,0.00016445511],"about_ca_topic_score_codex":0.00006270681,"about_ca_topic_score_gemma":0.00010615626,"teacher_disagreement_score":0.99188334,"about_ca_system_score_codex":0.00024459843,"about_ca_system_score_gemma":0.0014785379,"threshold_uncertainty_score":0.6969312},"labels":[],"label_agreement":null},{"id":"W2100143077","doi":"10.1053/j.seminoncol.2005.02.013","title":"Redefining Bronchioloalveolar Carcinoma","year":2005,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Histopathology; Adenocarcinoma; Lung cancer; Pathology; Carcinoma; Cancer; Natural history; Lung; Internal medicine","score_opus":0.04757776916274788,"score_gpt":0.44223082909283284,"score_spread":0.394653059930085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100143077","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000044898803,0.9180972,0.0000016886195,0.00018430107,0.00042506462,0.0007649224,0.000025506304,0.00003825782,0.080418155],"genre_scores_gemma":[0.000053785858,0.9910973,0.0026174162,0.00024255496,0.00044523418,0.0003234574,0.0003604371,0.0000589558,0.004800875],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983191,0.00012809299,0.0006001708,0.00045491647,0.00012039886,0.00037731772],"domain_scores_gemma":[0.9989629,0.00026815102,0.00024120662,0.00037840233,0.000030046533,0.00011932246],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019702823,0.00032844374,0.0018936355,0.00034976858,0.000051825293,0.0000065234904,0.00012997241,0.0006246105,0.00027254922],"category_scores_gemma":[0.0000868605,0.0002628554,0.00032809665,0.00030494152,0.000086134074,0.000029635357,0.00006796867,0.00061995053,0.0001934778],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012307277,0.00017865216,0.00024601456,0.0016661668,0.00014116138,0.0006255435,0.0002953526,4.294674e-7,1.1976614e-7,0.00012329775,0.0039865137,0.9927244],"study_design_scores_gemma":[0.00085081294,0.00061439,0.00007155326,0.00897438,0.0019517688,0.0010046829,0.00008180929,0.0000020234547,1.7400441e-7,0.000017878921,0.98623836,0.00019217],"about_ca_topic_score_codex":0.00005064555,"about_ca_topic_score_gemma":0.000049329818,"teacher_disagreement_score":0.99253225,"about_ca_system_score_codex":0.0022554772,"about_ca_system_score_gemma":0.0019861,"threshold_uncertainty_score":0.99998236},"labels":[],"label_agreement":null},{"id":"W2107019084","doi":"10.1053/j.seminoncol.2011.05.009","title":"Treatment of Metastatic Colorectal Cancer","year":2011,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Heritage Foundation for Medical Research","keywords":"Medicine; Colorectal cancer; Oncology; Chemotherapy; Internal medicine; Fluorouracil; Bevacizumab; Monoclonal antibody; Cancer; Antibody; Immunology","score_opus":0.0568908873638325,"score_gpt":0.36742412640277217,"score_spread":0.31053323903893965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107019084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94757324,0.006080141,0.0000013679804,0.00022900406,0.00021921295,0.00037804962,0.000014214311,0.000012710663,0.045492064],"genre_scores_gemma":[0.99197996,0.0053879865,0.001487388,0.00004686566,0.000027129128,0.0003044895,0.0000043071086,0.000009736218,0.0007521461],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931735,0.00003450085,0.00021936934,0.00016830422,0.00007368473,0.00018678384],"domain_scores_gemma":[0.9996585,0.00008523131,0.00007452685,0.000090743415,0.000041989697,0.000049002378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000043308977,0.000116765026,0.00050938677,0.00009866288,0.000019548945,5.865529e-7,0.000032824217,0.000050358634,0.00048282344],"category_scores_gemma":[0.00002034527,0.00008350564,0.00007517188,0.00015067625,0.00013713884,0.000016663675,0.000018694842,0.000042403546,0.0000064734195],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037428336,0.0038580187,0.50276846,0.00005135282,0.00060647517,0.0010703083,0.019265259,0.0000014470851,0.002562802,0.00026685811,0.00043592943,0.46537024],"study_design_scores_gemma":[0.01422789,0.058629822,0.8082133,0.00022180678,0.001127881,0.00042378687,0.0052213105,0.000080311336,0.06739741,0.00075536955,0.043375347,0.00032577512],"about_ca_topic_score_codex":0.0013616891,"about_ca_topic_score_gemma":0.0019602703,"teacher_disagreement_score":0.46504447,"about_ca_system_score_codex":0.00066761824,"about_ca_system_score_gemma":0.00020811732,"threshold_uncertainty_score":0.5286578},"labels":[],"label_agreement":null},{"id":"W2111959414","doi":"10.1016/s0093-7754(01)90215-5","title":"The effect of hemoglobin level on radiotherapy outcomes: The Canadian experience","year":2001,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Blood transfusion and management","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Radiation therapy; Univariate analysis; Anemia; Multivariate analysis; Internal medicine; Retrospective cohort study; Blood transfusion; Hemoglobin; Carcinoma; Stage (stratigraphy); Regimen; Surgery; Gastroenterology","score_opus":0.02303835331426013,"score_gpt":0.3452024190128664,"score_spread":0.3221640656986063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111959414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93425417,0.0006756039,0.00002503506,0.033749636,0.0005361613,0.0009477362,0.0000020068264,0.000013243137,0.029796412],"genre_scores_gemma":[0.98993516,0.001408313,0.00009623756,0.0050218785,0.000031979274,0.0001057797,0.0000013911409,0.00001031062,0.0033889785],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99909663,0.00014477338,0.00019187435,0.00014560977,0.00015485773,0.0002662712],"domain_scores_gemma":[0.9988113,0.00071240915,0.000040537132,0.00033712143,0.00001491318,0.00008370568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007804583,0.00010409846,0.00025973222,0.00008811244,0.00013195218,0.0000054607417,0.00020279545,0.0000917748,0.00011071292],"category_scores_gemma":[0.00013461208,0.00005068856,0.00006356917,0.0002026354,0.00021586099,0.000010991909,0.000014382847,0.00020455805,0.000009762773],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021626023,0.00028900124,0.3760914,0.000039318405,0.00016426634,0.00073059986,0.0080468375,0.00004759046,0.0016537491,0.0022576258,0.023664271,0.58485276],"study_design_scores_gemma":[0.004017037,0.0035898627,0.13071646,0.00009325641,0.000037429334,0.00010815859,0.0012009235,0.00007276608,0.0025279871,0.00003852511,0.8574999,0.00009767817],"about_ca_topic_score_codex":0.017490193,"about_ca_topic_score_gemma":0.18929236,"teacher_disagreement_score":0.83383566,"about_ca_system_score_codex":0.0003379953,"about_ca_system_score_gemma":0.00013276635,"threshold_uncertainty_score":0.9890524},"labels":[],"label_agreement":null},{"id":"W2112324274","doi":"10.1053/j.seminoncol.2004.07.019","title":"Optimizing treatment of HER2-positive metastatic breast cancer","year":2004,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Trastuzumab; Tolerability; Metastatic breast cancer; Breast cancer; Dosing; Oncology; Internal medicine; Regimen; Adverse effect; Clinical trial; Cancer","score_opus":0.044490724554963196,"score_gpt":0.42812279568189776,"score_spread":0.38363207112693454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112324274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9667418,0.007066236,0.00011406351,0.0117623145,0.00034280942,0.0011694131,0.00012439664,0.00003275198,0.012646202],"genre_scores_gemma":[0.978567,0.006639906,0.013244241,0.00032898595,0.00012604703,0.00030094248,0.000017152968,0.000036522124,0.000739199],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998665,0.000106590494,0.00032174855,0.00027970775,0.00023357457,0.0003934251],"domain_scores_gemma":[0.9992372,0.0002011214,0.00008686507,0.00023267668,0.000109702276,0.00013248032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002309243,0.00014771972,0.000572238,0.00021116222,0.000026929361,0.0000032762316,0.000089781606,0.00010581377,0.00042635624],"category_scores_gemma":[0.000041650444,0.00012492124,0.000082253435,0.00034360922,0.00023744773,0.00003402375,0.00003661637,0.0001763932,0.000020682292],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035014134,0.008378497,0.047240306,0.00047884427,0.00075141963,0.0064316723,0.02733485,0.005299314,0.031733587,0.0007976582,0.0012951083,0.86675733],"study_design_scores_gemma":[0.09214059,0.090549864,0.19855225,0.013828365,0.00216959,0.011623172,0.024626963,0.0014471271,0.45800123,0.004383103,0.10051976,0.0021579922],"about_ca_topic_score_codex":0.00321058,"about_ca_topic_score_gemma":0.0010028703,"teacher_disagreement_score":0.86459935,"about_ca_system_score_codex":0.00370582,"about_ca_system_score_gemma":0.0013198801,"threshold_uncertainty_score":0.96905905},"labels":[],"label_agreement":null},{"id":"W2113901864","doi":"10.1053/j.seminoncol.2005.04.019","title":"Current Management of Anal Canal Cancer","year":2005,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Colorectal and Anal Carcinomas","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Anal cancer; Capecitabine; Irinotecan; Radiation therapy; Oxaliplatin; Anal canal; Oncology; Mitomycin C; Surgery; Chemoradiotherapy; Fluorouracil; Chemotherapy; Internal medicine; Cancer; Colorectal cancer; Rectum","score_opus":0.07361723804546028,"score_gpt":0.4536214864930432,"score_spread":0.3800042484475829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113901864","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025932273,0.986273,5.9291597e-7,0.00009923455,0.0005331687,0.0005675178,0.00003731326,0.000009822481,0.012220049],"genre_scores_gemma":[0.00014352171,0.99776715,0.00017228276,0.00003914363,0.0003779243,0.00018316902,0.00007849668,0.000022980606,0.0012153564],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984169,0.00008277788,0.0006476813,0.0003413651,0.00020028651,0.0003109871],"domain_scores_gemma":[0.99929553,0.000076586075,0.00027255111,0.00020807941,0.000035501922,0.000111772664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020977919,0.00026391327,0.0018583777,0.00034938863,0.000014989992,0.0000017271622,0.00016572676,0.00024521296,0.00051954645],"category_scores_gemma":[0.000008955492,0.00020883887,0.0003630289,0.00045991072,0.00010330784,0.000012737567,0.0001379855,0.0005450318,0.000018055985],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043441265,0.00022987819,0.00020066583,0.013539069,0.00014718133,0.0005145548,0.000039333405,6.872939e-7,1.6576892e-7,0.00013994552,0.0029859932,0.9821591],"study_design_scores_gemma":[0.0003998074,0.00037158493,0.00031274147,0.029537225,0.0013200283,0.00014590341,0.00004125267,0.0000056711533,3.5288136e-7,0.000013859409,0.96769583,0.00015574036],"about_ca_topic_score_codex":0.00027436897,"about_ca_topic_score_gemma":0.0015143558,"teacher_disagreement_score":0.98200333,"about_ca_system_score_codex":0.0012838725,"about_ca_system_score_gemma":0.00072605285,"threshold_uncertainty_score":0.8516202},"labels":[],"label_agreement":null},{"id":"W2114829356","doi":"10.1053/j.seminoncol.2009.06.006","title":"Small Round Cell Sarcomas","year":2009,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Sarcoma; Chemotherapy; Radiation therapy; Chromosomal translocation; Lymphoma; Leukemia; Clear-cell sarcoma; Cancer; Oncology; Pathology; Cancer research; Internal medicine; Biology; Genetics","score_opus":0.08633677207263338,"score_gpt":0.38638368529394096,"score_spread":0.3000469132213076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114829356","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007624078,0.9417264,9.083369e-7,0.00029045355,0.00034619175,0.0012224389,0.000011479311,0.000042243177,0.056283645],"genre_scores_gemma":[0.000019078005,0.9936024,0.0022878966,0.00058820704,0.00026063932,0.00031200855,0.00019790752,0.00006216248,0.0026697223],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977077,0.00024850463,0.00075990096,0.0006052957,0.00015693856,0.00052165403],"domain_scores_gemma":[0.99811316,0.0007863313,0.00030083233,0.00058796303,0.00003306105,0.00017868241],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030588105,0.0005045959,0.0030362946,0.0004189444,0.000035751364,0.000011593543,0.0002187057,0.0009024331,0.00018296622],"category_scores_gemma":[0.00007048794,0.00039255345,0.00056259177,0.00036967176,0.00007917276,0.000017639075,0.0000877089,0.0007222992,0.00038536705],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017591947,0.0022492527,0.0002923339,0.0025641094,0.0000782381,0.0054503432,0.000060893548,7.8261294e-8,1.8611333e-7,0.00007252699,0.0063969996,0.9828175],"study_design_scores_gemma":[0.001145939,0.0014228265,0.00010233512,0.010072166,0.0014080541,0.0012572643,0.000035369205,6.218418e-7,0.0000029870685,0.000083178275,0.9841949,0.00027438093],"about_ca_topic_score_codex":0.000035765268,"about_ca_topic_score_gemma":0.00007904534,"teacher_disagreement_score":0.98254305,"about_ca_system_score_codex":0.0016735189,"about_ca_system_score_gemma":0.0008375426,"threshold_uncertainty_score":0.99985266},"labels":[],"label_agreement":null},{"id":"W2116041676","doi":"10.1053/j.seminoncol.2009.07.007","title":"The Adolescence of Young Adult Oncology","year":2009,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Subspecialty; Oncofertility; Medicine; Oncology; Population; Medical education; MEDLINE; Family medicine; Internal medicine; Public relations; Fertility preservation; Political science; Fertility","score_opus":0.018370180210441577,"score_gpt":0.35815608219071166,"score_spread":0.3397859019802701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116041676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87771213,0.003092654,0.000064030195,0.06284949,0.0011199357,0.00062530313,0.0000052052596,0.000058117064,0.054473154],"genre_scores_gemma":[0.9880739,0.0023912482,0.0019940794,0.0065605277,0.00027359757,0.000018366249,0.000005399283,0.000013468948,0.0006694441],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979176,0.00032042316,0.0007618036,0.0002967594,0.00028761552,0.00041580384],"domain_scores_gemma":[0.9981583,0.0007732534,0.00030729608,0.00047792585,0.00016735852,0.00011591962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013094036,0.00015391564,0.0006121063,0.000110303255,0.0000701909,0.000004124107,0.00029591072,0.0002892172,0.000033085966],"category_scores_gemma":[0.0012745145,0.00012112029,0.00010298092,0.00032504354,0.00038639712,0.00003988043,0.00005988633,0.0005347135,0.00002278863],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031875465,0.002391695,0.15172684,0.00015250039,0.000082054634,0.00065224187,0.015824502,0.000013464746,0.008284701,0.0106343925,0.04149217,0.7655579],"study_design_scores_gemma":[0.010820844,0.021175088,0.6905043,0.0022157794,0.00020518238,0.002179481,0.015839648,0.00026514544,0.009848607,0.008794897,0.23748036,0.00067063794],"about_ca_topic_score_codex":0.00027063626,"about_ca_topic_score_gemma":0.0021556818,"teacher_disagreement_score":0.7648872,"about_ca_system_score_codex":0.0005154397,"about_ca_system_score_gemma":0.00066271226,"threshold_uncertainty_score":0.49391422},"labels":[],"label_agreement":null},{"id":"W2116569903","doi":"10.1053/j.seminoncol.2005.04.014","title":"Introduction: Non-Small Cell Lung Cancer","year":2005,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Lung cancer; Cancer; Oncology; Internal medicine","score_opus":0.008520434493519578,"score_gpt":0.3504902629080791,"score_spread":0.34196982841455953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116569903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8344625,0.008252068,0.00010438703,0.051257893,0.0013548589,0.00068694475,0.000008905983,0.00005008434,0.103822336],"genre_scores_gemma":[0.9145354,0.003488568,0.013281445,0.0030975507,0.004836134,0.00046895436,0.00005562439,0.00003686158,0.060199443],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99931276,0.000018114344,0.00017264036,0.0002237488,0.00006477642,0.00020797494],"domain_scores_gemma":[0.99963844,0.00003342551,0.000049507777,0.0001640692,0.00004488954,0.00006965741],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008014727,0.00009221535,0.00020532843,0.000098327575,0.00003821117,0.000003614765,0.000045398334,0.00010478468,0.0010362549],"category_scores_gemma":[0.000012996582,0.00008167248,0.000037259695,0.00016289891,0.000040346396,0.00004004751,0.000020143525,0.00015960934,0.000059660986],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002735084,0.001511891,0.13850082,0.00015281777,0.00015965186,0.00026609516,0.007227777,0.0010575829,0.0052156392,0.00019415417,0.43047944,0.41496062],"study_design_scores_gemma":[0.0028721858,0.00043637585,0.01170445,0.00007620088,0.00024947317,0.00009090165,0.00047788292,0.00055002817,0.0039667455,0.000019569106,0.9794437,0.000112483205],"about_ca_topic_score_codex":0.0001267053,"about_ca_topic_score_gemma":0.0003953656,"teacher_disagreement_score":0.54896426,"about_ca_system_score_codex":0.0011002778,"about_ca_system_score_gemma":0.00042072908,"threshold_uncertainty_score":0.9998769},"labels":[],"label_agreement":null},{"id":"W2117206782","doi":"10.1053/j.seminoncol.2007.07.010","title":"Clinically Relevant Biology of Hereditary Breast Cancer","year":2007,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Breast cancer; BRCA2 Protein; Identification (biology); Gene; Epidemiology; Cancer; Genetics; Mutation; Bioinformatics; Computational biology; Pathology; Biology; Germline mutation; Internal medicine","score_opus":0.04336574340209221,"score_gpt":0.4329801532678643,"score_spread":0.3896144098657721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117206782","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031485493,0.99433476,0.00005350673,0.000108218825,0.0018979936,0.00051595975,0.0005578021,0.000009765677,0.0022071688],"genre_scores_gemma":[0.0001410553,0.9947898,0.0026167203,0.0002047916,0.0010589844,0.0002344783,0.00041267512,0.00007791541,0.0004636027],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966415,0.00041372687,0.0015314709,0.0008051109,0.000114483635,0.000493672],"domain_scores_gemma":[0.99789155,0.0003489653,0.00080478046,0.0007037178,0.00015842459,0.000092539354],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0010693937,0.00041308656,0.0016800683,0.00028411884,0.000028796874,0.0000030940769,0.00066739845,0.0020249616,0.00014005533],"category_scores_gemma":[0.0002266315,0.00037942838,0.00035564814,0.000379887,0.00052886875,0.000002105512,0.00035944086,0.00061374676,0.00001768672],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095362455,0.0001599019,0.0002536731,0.001392292,0.0002066056,0.000046873785,0.000028667184,0.0000087761455,0.00012464041,0.000028720922,0.009576168,0.9880783],"study_design_scores_gemma":[0.0003968329,0.000699931,0.000023895764,0.0024221994,0.00022477166,0.00043586665,0.00003538094,0.0000016984313,0.000051596813,0.000079680474,0.9952836,0.0003445491],"about_ca_topic_score_codex":0.00009193709,"about_ca_topic_score_gemma":0.0003131604,"teacher_disagreement_score":0.9877338,"about_ca_system_score_codex":0.0005493622,"about_ca_system_score_gemma":0.0030187375,"threshold_uncertainty_score":0.9998658},"labels":[],"label_agreement":null},{"id":"W2119780823","doi":"10.1053/j.seminoncol.2009.03.003","title":"Cancer in Young Adults 20 to 39 Years of Age: Overview","year":2009,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster Children's Hospital","funders":"","keywords":"Medicine; Psychosocial; Young adult; Cancer; Epidemiology; Disease; Etiology; Ethnic group; Gerontology; Depression (economics); Pediatrics; Psychiatry; Internal medicine","score_opus":0.05565798392498606,"score_gpt":0.4336531959786632,"score_spread":0.37799521205367714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119780823","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013794196,0.9908762,6.9600367e-7,0.0008859519,0.0010719147,0.0019249923,0.00010632188,0.000028043904,0.003726478],"genre_scores_gemma":[0.0000710746,0.9961648,0.00067536056,0.0012689941,0.0004177213,0.00026702473,0.00008865103,0.00007123518,0.0009751163],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995925,0.00057219894,0.0017241838,0.000747885,0.00044879413,0.00058195833],"domain_scores_gemma":[0.9978419,0.0005321637,0.0006032167,0.0007312644,0.000068827634,0.00022261095],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012446027,0.00045368893,0.004567161,0.0007975141,0.000012092283,0.0000051996317,0.000455511,0.0008741931,0.0002658319],"category_scores_gemma":[0.00062504294,0.00047601378,0.00041001453,0.0012681022,0.00011378866,0.000039206683,0.00018270945,0.0010885273,0.00005878359],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001318537,0.00035950608,0.00045459488,0.014276121,0.00007021159,0.00070564775,0.0024465213,0.0000019764248,7.2960734e-7,0.000028313012,0.0065825414,0.97494197],"study_design_scores_gemma":[0.0011450561,0.0008385336,0.0030557108,0.12439024,0.00029533042,0.00013327645,0.00015451199,6.9854127e-7,8.03692e-7,0.00004066469,0.86961514,0.00033005275],"about_ca_topic_score_codex":0.0037331337,"about_ca_topic_score_gemma":0.03749957,"teacher_disagreement_score":0.97461194,"about_ca_system_score_codex":0.0018919356,"about_ca_system_score_gemma":0.001860834,"threshold_uncertainty_score":0.99976915},"labels":[],"label_agreement":null},{"id":"W2122479458","doi":"10.1053/j.seminoncol.2011.03.016","title":"Pharmacologic Management of Cancer-Related Pain, Dyspnea, and Nausea","year":2011,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Nausea and vomiting management","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Ontario Institute for Cancer Research; BC Cancer Agency","funders":"","keywords":"Medicine; Nausea; Palliative care; Cancer pain; Cancer; Intensive care medicine; Pain medicine; Randomized controlled trial; Clinical trial; Distress; Surgery; Internal medicine; Anesthesia","score_opus":0.06969079970934558,"score_gpt":0.4307987234994413,"score_spread":0.3611079237900957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122479458","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002670355,0.9735126,0.0000030694937,0.00011313511,0.00048508547,0.0019419279,0.00000941705,0.000060881244,0.02360687],"genre_scores_gemma":[0.00010886207,0.9948277,0.001115763,0.00019450221,0.00005996415,0.00044991766,0.00003402335,0.000046918314,0.0031623775],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975672,0.00042434252,0.0009249234,0.0005313141,0.00014180041,0.00041044687],"domain_scores_gemma":[0.99862134,0.00033444725,0.000555311,0.00032763253,0.000045085493,0.00011620579],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014879629,0.0003742953,0.0021240143,0.00045780046,0.00003043882,0.0000036099955,0.00023195684,0.00052267814,0.00041776395],"category_scores_gemma":[0.000040726252,0.0003078632,0.0001934166,0.0004644956,0.0001672512,0.000020871747,0.00030525116,0.0005625256,0.00002178685],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046624387,0.000427131,0.00021173862,0.03585174,0.0010017334,0.00096667814,0.0001418011,1.2216022e-7,7.73991e-7,0.00055624085,0.004527623,0.9562678],"study_design_scores_gemma":[0.0014338562,0.0008503887,0.00007644964,0.022030251,0.0040546414,0.00006053866,0.00010918305,0.0000071259306,0.0000024056449,0.00014179165,0.97099996,0.000233416],"about_ca_topic_score_codex":0.0000570483,"about_ca_topic_score_gemma":0.000013207836,"teacher_disagreement_score":0.9664723,"about_ca_system_score_codex":0.000580862,"about_ca_system_score_gemma":0.00018852248,"threshold_uncertainty_score":0.99993736},"labels":[],"label_agreement":null},{"id":"W2122748411","doi":"10.1053/j.seminoncol.2010.06.004","title":"Bisphosphonates in Lung Cancer: More Than a Palliative Therapy?","year":2010,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Novartis Pharmaceuticals Corporation; Bayer Corporation; Bristol-Myers Squibb","keywords":"Medicine; Zoledronic acid; Lung cancer; Cancer; Oncology; Internal medicine; Clinical trial; Adjuvant therapy; Palliative care; Surgery; Nursing","score_opus":0.047669674698986975,"score_gpt":0.4557951072149968,"score_spread":0.4081254325160098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122748411","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025668242,0.9918507,1.1610126e-7,0.0007470878,0.0008142743,0.0024122396,0.000054067346,0.00002875278,0.0015259371],"genre_scores_gemma":[0.000106384636,0.9951793,0.00035024842,0.0005368309,0.00008050761,0.00188074,0.00016944385,0.00006920152,0.001627367],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977261,0.00018462018,0.00073788466,0.00056111056,0.00016972992,0.0006205787],"domain_scores_gemma":[0.9984853,0.00053304655,0.00037246343,0.00036499763,0.000045013767,0.00019917893],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00031432704,0.00046102403,0.0026550859,0.00041130657,0.000035809575,0.000004436061,0.00017594289,0.0013024659,0.00019363509],"category_scores_gemma":[0.00010132405,0.00033870578,0.00023255461,0.0006018444,0.00014212035,0.000026907574,0.000059140348,0.0016819171,0.000027588074],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015324526,0.0005053885,0.028186055,0.0038796673,0.000109802335,0.0010051912,0.0007413222,8.3527866e-8,2.790438e-7,0.000014929183,0.0007744868,0.96462953],"study_design_scores_gemma":[0.0023263807,0.0005483568,0.0027403145,0.019929966,0.00024327567,0.00008736356,0.00005439496,0.000008005016,0.0000029233743,0.000034415658,0.9737987,0.00022590121],"about_ca_topic_score_codex":0.0030431303,"about_ca_topic_score_gemma":0.0067312378,"teacher_disagreement_score":0.9730242,"about_ca_system_score_codex":0.0017288979,"about_ca_system_score_gemma":0.0028320423,"threshold_uncertainty_score":0.99999404},"labels":[],"label_agreement":null},{"id":"W2127462608","doi":"10.1053/j.seminoncol.2004.07.020","title":"Maximizing clinical benefit with trastuzumab","year":2004,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Trastuzumab; Medicine; Vinorelbine; Oncology; Metastatic breast cancer; Internal medicine; Taxane; Capecitabine; Breast cancer; Chemotherapy; Gemcitabine; Clinical trial; Cancer; Colorectal cancer","score_opus":0.17623130803002254,"score_gpt":0.5363274342574647,"score_spread":0.36009612622744214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127462608","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006723323,0.97785324,0.000013190027,0.00039766578,0.00060446246,0.0019174712,0.000020773528,0.00006288511,0.019063072],"genre_scores_gemma":[0.000012567621,0.99066335,0.005594985,0.00022158556,0.00063745154,0.00045225272,0.0000948467,0.00015882138,0.0021641504],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99555314,0.0004099705,0.0015236709,0.0010124539,0.00056688633,0.00093388103],"domain_scores_gemma":[0.99688333,0.0013378393,0.00039765367,0.0008770732,0.000118510725,0.00038556132],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.001990373,0.00053795124,0.004351234,0.00057188503,0.000051287774,0.00001571997,0.0005125382,0.0015879557,0.0004958661],"category_scores_gemma":[0.000520955,0.00040216726,0.0004942119,0.00085524993,0.000541638,0.000034983128,0.00021431856,0.0034580666,0.0003100894],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00017875587,0.0005113414,0.00031243084,0.014653869,0.00017081923,0.004632958,0.00010155565,0.0000018271948,6.7137314e-8,0.0001140451,0.0015587282,0.9777636],"study_design_scores_gemma":[0.0018340746,0.004645756,0.000046632875,0.08123073,0.00059344707,0.0029267133,0.00007080985,0.0000016295339,4.071354e-7,0.000099020974,0.9082304,0.0003203428],"about_ca_topic_score_codex":0.00009520855,"about_ca_topic_score_gemma":0.00025476076,"teacher_disagreement_score":0.9774433,"about_ca_system_score_codex":0.005213581,"about_ca_system_score_gemma":0.008918379,"threshold_uncertainty_score":0.999843},"labels":[],"label_agreement":null},{"id":"W2130773839","doi":"10.1016/s0093-7754(01)90290-8","title":"The role of genetic abnormalities of PTEN and the phosphatidylinositol 3-kinase pathway in breast and ovarian tumorigenesis, prognosis, and therapy","year":2001,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":130,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto","funders":"National Cancer Institute","keywords":"PTEN; Cancer research; Medicine; Ovarian cancer; Breast cancer; Carcinogenesis; Cowden syndrome; Tumor suppressor gene; Oncology; PI3K/AKT/mTOR pathway; Cancer; Internal medicine; Signal transduction; Biology; Genetics","score_opus":0.010687799143218856,"score_gpt":0.2841705723610131,"score_spread":0.27348277321779424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130773839","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03635721,0.9622849,0.0000015901256,0.000075072356,0.00010658809,0.00084268494,0.00006266118,0.0000026756663,0.00026656679],"genre_scores_gemma":[0.026555365,0.97271013,0.00015270022,0.00003890673,0.000108878216,0.00032379176,0.000023412464,0.00003275038,0.00005408118],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99783176,0.00059756305,0.0007308171,0.00041769864,0.00011918259,0.00030295],"domain_scores_gemma":[0.9986086,0.00043331715,0.0004926204,0.0003537433,0.0000621274,0.00004957381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009158078,0.00031834622,0.0010232284,0.00008634633,0.00006831253,0.000017011975,0.00032514677,0.00044454884,0.0000048391894],"category_scores_gemma":[0.000062393396,0.00019815662,0.000102229766,0.00017850185,0.0010371607,0.0000037642078,0.00021115012,0.00022956324,1.2340399e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028534804,0.0000811088,0.006601798,0.0006866258,0.00010651465,0.000015378177,0.00028525555,0.000001457151,0.00042457762,0.00016943798,0.000046830424,0.9912957],"study_design_scores_gemma":[0.0018293383,0.000643683,0.0012948392,0.0022004053,0.00012134644,0.00059680274,0.0004545638,0.000014752953,0.0030113035,0.0004364005,0.98907,0.00032655167],"about_ca_topic_score_codex":0.00025591208,"about_ca_topic_score_gemma":0.00016717584,"teacher_disagreement_score":0.9909691,"about_ca_system_score_codex":0.000040132378,"about_ca_system_score_gemma":0.00039223002,"threshold_uncertainty_score":0.8080592},"labels":[],"label_agreement":null},{"id":"W2130986264","doi":"10.1016/s0093-7754(01)90297-0","title":"Docetaxel (Taxotere) shows survival and quality-of-life benefits in the second-line treatment of non-small cell lung cancer: A review of two phase III trials","year":2001,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Docetaxel; Medicine; Vinorelbine; Ifosfamide; Lung cancer; Chemotherapy; Internal medicine; Oncology; Phases of clinical research; Cancer; Surgery; Cisplatin","score_opus":0.1612092728561817,"score_gpt":0.5138659854352491,"score_spread":0.3526567125790674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130986264","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010652273,0.97962844,0.000005617977,0.00020931839,0.00028900598,0.005311103,0.0009977575,0.000004670133,0.0029018326],"genre_scores_gemma":[0.00040286416,0.99660677,0.00037465224,0.00017460808,0.00015517756,0.0011256166,0.00035497954,0.00003448572,0.0007708335],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945167,0.0013650437,0.003100985,0.00046494912,0.00024123001,0.00031113473],"domain_scores_gemma":[0.99435663,0.002521326,0.0023279113,0.0005515564,0.00013368935,0.000108885586],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026288503,0.00047258558,0.0074435687,0.00032979302,0.000024465156,0.0000032114376,0.00020468666,0.0003143983,0.0003556702],"category_scores_gemma":[0.0002620548,0.00028656458,0.00059399207,0.00059226155,0.00014414875,0.000028265898,0.000045620516,0.00025495,6.6565167e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003097288,0.002887952,0.0005823531,0.098383754,0.0006909946,0.00006356101,0.0010651674,0.000002067482,0.000010982287,0.000063963314,0.0002477603,0.8956917],"study_design_scores_gemma":[0.03336781,0.004263818,0.000050570652,0.13039687,0.010068374,0.00006500216,0.00037946342,0.000007892775,0.000053040956,0.000012820432,0.8210079,0.00032641328],"about_ca_topic_score_codex":0.0018330938,"about_ca_topic_score_gemma":0.0038940478,"teacher_disagreement_score":0.8953653,"about_ca_system_score_codex":0.0007367112,"about_ca_system_score_gemma":0.0023822207,"threshold_uncertainty_score":0.99995863},"labels":[],"label_agreement":null},{"id":"W2139267872","doi":"10.1053/j.seminoncol.2009.07.002","title":"Introduction—Impact of Malignant Diseases on Young Adults II","year":2009,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Skin cancer; Psychological intervention; Randomized controlled trial; Intervention (counseling); Young adult; Sun protection; Cancer; Incidence (geometry); Sun exposure; Dermatology; Gerontology; Surgery; Internal medicine; Psychiatry","score_opus":0.008792579588856292,"score_gpt":0.3212122971257511,"score_spread":0.3124197175368948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139267872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98873216,0.000310971,0.00001249189,0.0058165058,0.00040178743,0.00024995557,0.000003710328,0.000035068028,0.0044373698],"genre_scores_gemma":[0.997788,0.00018015299,0.000243315,0.00033668967,0.0004763122,0.00001061884,0.0000102222075,0.000006731441,0.0009479322],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99924195,0.000047765596,0.00021985,0.00020317106,0.000109544366,0.00017774657],"domain_scores_gemma":[0.9995696,0.000045108452,0.000082184524,0.00018395146,0.00004605132,0.00007309701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012903646,0.000093281575,0.00026935944,0.00021170694,0.00003944951,0.0000017301392,0.000046729478,0.00008559315,0.00035259704],"category_scores_gemma":[0.00030916661,0.00007374029,0.00008707713,0.00023276526,0.00005292862,0.00002999132,0.000015562262,0.00017668345,0.000013108064],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074286717,0.004164084,0.10988891,0.00007361564,0.000089958456,0.0006379046,0.0030173936,0.0003777775,0.032334507,0.00088202686,0.07321359,0.7678916],"study_design_scores_gemma":[0.005696121,0.024792224,0.93020016,0.0010969383,0.00009483659,0.001144356,0.0009539162,0.00045958135,0.01311581,0.0010678804,0.021099493,0.00027865655],"about_ca_topic_score_codex":0.000047257876,"about_ca_topic_score_gemma":0.0000074015225,"teacher_disagreement_score":0.82031125,"about_ca_system_score_codex":0.0003192056,"about_ca_system_score_gemma":0.00010646737,"threshold_uncertainty_score":0.38606903},"labels":[],"label_agreement":null},{"id":"W2139472998","doi":"10.1053/j.seminoncol.2005.09.008","title":"Gene Therapy of the Typical Multidrug Resistance Phenotype of Cancers: A New Hope?","year":2005,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University","funders":"","keywords":"Medicine; Clinical trial; Multiple drug resistance; Mechanism (biology); Genetic enhancement; Phenotype; Bioinformatics; Gene; Drug resistance; Computational biology; Biology; Genetics; Internal medicine","score_opus":0.035102224983052516,"score_gpt":0.35328724436733006,"score_spread":0.31818501938427757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139472998","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00397415,0.99391615,0.000008723304,0.00005974904,0.00033971237,0.00038743205,0.0000453759,0.0000022482727,0.0012664644],"genre_scores_gemma":[0.0011111631,0.99487764,0.00087444874,0.000115891,0.00033015688,0.000034420293,0.00004286955,0.000027659402,0.0025857543],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984485,0.00023169495,0.0006064492,0.00037242402,0.000110755,0.00023019209],"domain_scores_gemma":[0.9987347,0.00006454578,0.00048347277,0.0006039314,0.00006903603,0.000044289078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019795621,0.00025239278,0.0009473655,0.00006727954,0.000018619763,0.000002595038,0.00068780844,0.00060194085,0.000048638198],"category_scores_gemma":[0.000092176975,0.0001772057,0.0003372228,0.00019407712,0.0002062115,0.0000020220004,0.00017406138,0.0002621398,0.000005189225],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024765995,0.000089835645,0.000025649804,0.00031579394,0.00010977491,0.0000037247535,0.00010703018,0.000009318806,0.0026173424,0.000016840364,0.0100739105,0.98638314],"study_design_scores_gemma":[0.00036649546,0.00033014413,0.000023636589,0.0018264692,0.000052278516,0.000010159172,0.000024157096,8.687026e-7,0.0044780564,0.000029455143,0.9926932,0.00016507201],"about_ca_topic_score_codex":0.00009610847,"about_ca_topic_score_gemma":0.0011648731,"teacher_disagreement_score":0.98621804,"about_ca_system_score_codex":0.00013839577,"about_ca_system_score_gemma":0.0015860052,"threshold_uncertainty_score":0.7226239},"labels":[],"label_agreement":null},{"id":"W2156093622","doi":"10.1053/j.seminoncol.2009.03.005","title":"Psychosocial Issues and Quality of Life","year":2009,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Psychosocial; Medicine; Generativity; Quality of life (healthcare); Psychological intervention; Gerontology; Compromise; Childhood cancer; Cancer; Developmental psychology; Psychiatry; Nursing; Psychology","score_opus":0.11098618069487141,"score_gpt":0.48913571601031897,"score_spread":0.37814953531544754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156093622","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00065970386,0.9888689,0.0000016797774,0.0023403275,0.00051529234,0.0008892599,0.00003852277,0.00003548025,0.0066508367],"genre_scores_gemma":[0.00003272319,0.9960013,0.0012147946,0.0011830857,0.0008147802,0.00004228303,0.00006320344,0.000040195064,0.0006076072],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957683,0.0011119298,0.001831817,0.0005694338,0.00036961923,0.00034891273],"domain_scores_gemma":[0.9970782,0.0011620102,0.000961458,0.00051251973,0.00007188666,0.0002139161],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022717258,0.00039328178,0.0052424297,0.00031270008,0.000028763292,0.0000055947867,0.00022554205,0.0010473061,0.000106271196],"category_scores_gemma":[0.0015717404,0.00036627252,0.0003916019,0.00038593847,0.00033972925,0.000032553,0.00009692104,0.0008415377,0.000016778813],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013010287,0.0004244233,0.00051297125,0.018432654,0.00013575677,0.000023869265,0.0012092645,1.5556433e-8,5.18963e-7,0.0004025729,0.011007203,0.9677206],"study_design_scores_gemma":[0.0010980245,0.00091463525,0.001020498,0.017706165,0.00033401384,0.000048250236,0.00023619634,1.01882925e-7,5.0015717e-7,0.0003157872,0.978054,0.0002718521],"about_ca_topic_score_codex":0.000589227,"about_ca_topic_score_gemma":0.000593826,"teacher_disagreement_score":0.9674488,"about_ca_system_score_codex":0.00034738157,"about_ca_system_score_gemma":0.0013413852,"threshold_uncertainty_score":0.99987894},"labels":[],"label_agreement":null},{"id":"W2156946556","doi":"10.1053/sonc.2002.31672","title":"Radioembolization for hepatic metastases","year":2002,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal General Hospital","funders":"","keywords":"Medicine; Radiology; Nuclear medicine","score_opus":0.08558073659995405,"score_gpt":0.3146175871290862,"score_spread":0.22903685052913217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156946556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801411,0.006305007,0.0005013476,0.0020869835,0.00021098516,0.001090729,0.000013191948,0.000048522186,0.009602114],"genre_scores_gemma":[0.98927,0.0009082886,0.007550275,0.0004395611,0.00008894371,0.0002506568,0.000086573404,0.000016601723,0.0013891193],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99928474,0.000062948,0.00019919203,0.00017475167,0.00007163299,0.00020674759],"domain_scores_gemma":[0.9994837,0.00023925668,0.000045636592,0.00013106916,0.000035183086,0.000065174885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017762321,0.00009592224,0.0003045353,0.00014301226,0.000032412696,0.00000397417,0.000039015857,0.0001097781,0.0004435677],"category_scores_gemma":[0.000162079,0.00008572464,0.00007911969,0.00017440859,0.000040799394,0.00003425308,0.000010869309,0.00006515459,0.000045907513],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018320222,0.0009816606,0.70711577,0.00011689142,0.00008711258,0.00044031095,0.0010898166,0.0000026565715,0.001341542,0.0005274883,0.018757412,0.26935613],"study_design_scores_gemma":[0.015420327,0.010051181,0.012861456,0.00036167298,0.0011727968,0.00068748643,0.000527361,0.084829554,0.02561505,0.0015541444,0.8463569,0.00056205905],"about_ca_topic_score_codex":0.000012964909,"about_ca_topic_score_gemma":0.000020364974,"teacher_disagreement_score":0.8275995,"about_ca_system_score_codex":0.00017775396,"about_ca_system_score_gemma":0.00003190059,"threshold_uncertainty_score":0.4856755},"labels":[],"label_agreement":null},{"id":"W2162641301","doi":"10.1053/j.seminoncol.2015.07.003","title":"The Globalization of Cooperative Groups","year":2015,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Impact; Queen's University","funders":"Canadian Cancer Society Research Institute; National Institutes of Health; National Cancer Institute; Bill and Melinda Gates Foundation","keywords":"Medicine; Latin Americans; Clinical trial; Cancer; Globalization; Family medicine; Working group; Economic growth; Political science; Pathology; Internal medicine; Law","score_opus":0.0252713700555133,"score_gpt":0.36049856834563615,"score_spread":0.3352271982901229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162641301","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000055224613,0.99437886,0.0000455021,0.0000258934,0.00054655876,0.00038770307,0.000080817,0.0000018891549,0.0044775605],"genre_scores_gemma":[0.000040106435,0.998818,0.000115786,0.000047080226,0.00021419661,0.00007898589,0.00035563775,0.000021588183,0.00030864333],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988602,0.00019788071,0.00043444577,0.00024995243,0.00007582567,0.0001817005],"domain_scores_gemma":[0.99904776,0.0001602164,0.00029158872,0.00032349952,0.00013372932,0.00004320952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046907796,0.00017791889,0.00063350576,0.000038937374,0.000035889312,0.00000889648,0.00030898055,0.00044858592,0.0000038584453],"category_scores_gemma":[0.00042290761,0.00012962638,0.0001150034,0.00016298569,0.00017479723,8.0883086e-7,0.00020409757,0.00013034204,0.0000058065352],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026505775,0.000052170526,0.000010912023,0.0003063765,0.000050680042,0.0000066545867,0.00003972307,0.000022813349,0.000013506344,0.001099215,0.022969382,0.97540206],"study_design_scores_gemma":[0.00018565543,0.00050856906,8.81854e-7,0.000532639,0.00007799712,0.000027635835,0.00005933893,0.000003739788,0.000026630658,0.00013423931,0.99831516,0.00012752763],"about_ca_topic_score_codex":0.00001616055,"about_ca_topic_score_gemma":0.0003400609,"teacher_disagreement_score":0.9753458,"about_ca_system_score_codex":0.00019904168,"about_ca_system_score_gemma":0.0011685438,"threshold_uncertainty_score":0.528601},"labels":[],"label_agreement":null},{"id":"W2170700422","doi":"10.1053/j.seminoncol.2009.12.005","title":"Adjuvant Chemotherapy for Resected Stage II and III Colon Cancer: Comparison of Two Widely Used Prognostic Calculators","year":2010,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; FOLFOX; Colorectal cancer; Oxaliplatin; Adjuvant; Numeracy; Oncology; Internal medicine; Stage (stratigraphy); Fluorouracil; Adjuvant therapy; Adjuvant chemotherapy; Surgery; Chemotherapy; Cancer; Breast cancer","score_opus":0.03339839090572973,"score_gpt":0.4159180694435799,"score_spread":0.3825196785378502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170700422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952719,0.0010718857,0.000010835391,0.00091870216,0.00042435442,0.0017932606,0.000040671297,0.00003487987,0.00043350054],"genre_scores_gemma":[0.99685395,0.0001817751,0.001785881,0.00013863733,0.00006993673,0.00044755428,0.000028468958,0.000029105691,0.00046470104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862635,0.000055933753,0.00044476462,0.00035573737,0.00017645203,0.00034076592],"domain_scores_gemma":[0.99862456,0.000690567,0.00020862302,0.00020828741,0.000123471,0.00014449604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027591683,0.00018299323,0.0008825792,0.00014017671,0.00009138566,0.0000029287808,0.00008924301,0.00024564585,0.00014713149],"category_scores_gemma":[0.0002488198,0.00015930337,0.00007033242,0.00027790293,0.00027704795,0.000032262895,0.00008789555,0.00034417678,5.351654e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052577974,0.0011965594,0.8559969,0.00013000908,0.00012228214,0.000068518006,0.0036951196,0.000016924769,0.07269353,0.00016121795,0.0005878707,0.06007325],"study_design_scores_gemma":[0.08132134,0.036611877,0.5473104,0.000984418,0.0005851015,0.00012479853,0.0010797754,0.010281905,0.19036958,0.0005849505,0.12996086,0.00078497035],"about_ca_topic_score_codex":0.00073068845,"about_ca_topic_score_gemma":0.006982784,"teacher_disagreement_score":0.3086865,"about_ca_system_score_codex":0.00034072163,"about_ca_system_score_gemma":0.00037137236,"threshold_uncertainty_score":0.6496203},"labels":[],"label_agreement":null},{"id":"W2755955412","doi":"10.1053/j.seminoncol.2017.08.004","title":"Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients","year":2017,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Ovarian cancer; Olaparib; Medicine; Germline; Genetic testing; Germline mutation; PARP inhibitor; Oncology; Cancer; Somatic cell; Breast cancer; Internal medicine; BRCA mutation; Mutation; Cancer research; Gynecology; Polymerase; Poly ADP ribose polymerase; Genetics; DNA; Biology; Gene","score_opus":0.07812918806627712,"score_gpt":0.42382383054090716,"score_spread":0.34569464247463005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755955412","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014695871,0.9900349,0.000004932134,0.00007519507,0.0014068417,0.0010035633,0.00018035558,0.0000075417233,0.0058171083],"genre_scores_gemma":[0.00062396075,0.9946919,0.0014818648,0.00026171975,0.00038207896,0.0013907443,0.00029192746,0.00008250845,0.0007932937],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971369,0.00032509843,0.0009439172,0.000891587,0.0001751959,0.00052733533],"domain_scores_gemma":[0.9980178,0.0001416673,0.00087132765,0.0007856556,0.00011283719,0.00007075026],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006491616,0.00043618318,0.0010760612,0.0002459283,0.0000870996,0.000023854245,0.00073037745,0.00053933484,0.000037490012],"category_scores_gemma":[0.00088649587,0.00043174697,0.00013400367,0.00022352353,0.0001445795,0.000004480083,0.00032814965,0.00048755342,0.000026736237],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030550986,0.00025223565,0.0027588492,0.0010412745,0.00005332841,0.000070538714,0.00005292438,0.00007870041,0.000029413277,0.000007897971,0.0055670785,0.99005723],"study_design_scores_gemma":[0.0007699804,0.00049467845,0.0007508644,0.007333492,0.0000584009,0.00001294566,0.000014179218,0.0000055448063,0.000073153504,0.00002883951,0.9900442,0.00041373272],"about_ca_topic_score_codex":0.00017910195,"about_ca_topic_score_gemma":0.00090320985,"teacher_disagreement_score":0.98964345,"about_ca_system_score_codex":0.0021632141,"about_ca_system_score_gemma":0.0025105558,"threshold_uncertainty_score":0.99981344},"labels":[],"label_agreement":null},{"id":"W2765724600","doi":"10.1053/j.seminoncol.2017.10.009","title":"Management of stage III non–small cell lung cancer","year":2017,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Context (archaeology); Malignancy; Immunotherapy; Lung cancer; Disease; Intensive care medicine; Stage (stratigraphy); Cancer; Radiation therapy; Oncology; Surgery; Internal medicine","score_opus":0.05417943617264763,"score_gpt":0.43365465582967,"score_spread":0.37947521965702236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765724600","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015935207,0.9361338,0.0000022941267,0.00010008388,0.00080365967,0.0023651887,0.00006893268,0.000011876628,0.06035483],"genre_scores_gemma":[0.00007667173,0.97282314,0.000690272,0.000051784675,0.00014550966,0.0016917671,0.00008017569,0.000055952056,0.02438474],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99808913,0.00007416293,0.0007212754,0.00054694904,0.00017727094,0.00039120682],"domain_scores_gemma":[0.9980414,0.00014688322,0.0007908113,0.0008631446,0.00004546735,0.000112318085],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030615096,0.00039567307,0.0027826782,0.00023314505,0.000043272164,0.000007193713,0.00033069646,0.00046685932,0.00034846406],"category_scores_gemma":[0.0000068180157,0.00030886356,0.00040508562,0.00013168948,0.00010355587,0.000020060543,0.0002331672,0.0003843354,0.00001929032],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003781672,0.00067615643,0.0010770161,0.0706539,0.00068964815,0.0022562796,0.00015186523,0.0000012848516,1.0562512e-7,0.00004417093,0.006276374,0.9181354],"study_design_scores_gemma":[0.0020205851,0.00045456065,0.00014178926,0.075611636,0.004334823,0.000020526253,0.00005920014,0.0000036446793,0.000008289254,0.0000028771783,0.91714054,0.0002015297],"about_ca_topic_score_codex":0.00043935387,"about_ca_topic_score_gemma":0.0002856913,"teacher_disagreement_score":0.9179338,"about_ca_system_score_codex":0.0029335623,"about_ca_system_score_gemma":0.00094537425,"threshold_uncertainty_score":0.99993634},"labels":[],"label_agreement":null},{"id":"W2792041391","doi":"10.1053/j.seminoncol.2018.01.009","title":"Cell-free DNA as a post-treatment surveillance strategy: current status","year":2017,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research; Princess Margaret Cancer Foundation","keywords":"Medicine; Minimal residual disease; Epigenetics; Cell-free fetal DNA; Computational biology; Circulating tumor DNA; Cancer; DNA; Bioinformatics; Internal medicine; Genetics; Biology; Gene","score_opus":0.04472230872259286,"score_gpt":0.39301490682007023,"score_spread":0.34829259809747737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792041391","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011430332,0.98676115,0.000002153013,0.000043070813,0.0014322372,0.00086837565,0.0010288084,0.000009611599,0.008711586],"genre_scores_gemma":[0.00020687723,0.9956357,0.000114867646,0.000054347704,0.00063029985,0.0003150529,0.0018505554,0.00008009701,0.0011122231],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99742776,0.0002195201,0.00062997476,0.00088049116,0.00012502934,0.00071723433],"domain_scores_gemma":[0.9972848,0.00019070778,0.0006201936,0.0015939692,0.0000986225,0.00021169444],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026847076,0.00059654505,0.0015164689,0.00013782995,0.000101693106,0.000056047124,0.0008371414,0.00079899287,0.00004167016],"category_scores_gemma":[0.00041671176,0.0005446172,0.00041991175,0.00007638642,0.00017866278,0.0000026591188,0.0005466816,0.0003361198,0.000080454694],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047469373,0.00036434634,0.00007157381,0.00096084847,0.00007802048,0.00013870123,0.0000346421,0.0000052339606,0.00003735013,0.000037374633,0.00834476,0.98987967],"study_design_scores_gemma":[0.00088722096,0.0025571857,0.000020062014,0.0008946563,0.00013859039,0.00007805258,0.00002979949,9.0210483e-7,0.00005664463,0.000081965656,0.9947709,0.00048404752],"about_ca_topic_score_codex":0.00034069445,"about_ca_topic_score_gemma":0.0025260046,"teacher_disagreement_score":0.9893956,"about_ca_system_score_codex":0.0007527308,"about_ca_system_score_gemma":0.00397945,"threshold_uncertainty_score":0.99970055},"labels":[],"label_agreement":null},{"id":"W2908061515","doi":"10.1053/j.seminoncol.2018.12.006","title":"Medical oncology job satisfaction: Results of a global survey","year":2019,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Healthcare professionals’ stress and burnout","field":"Health Professions","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"","keywords":"Medicine; Job satisfaction; Oncology; MEDLINE; Patient satisfaction; Internal medicine; Family medicine; Nursing","score_opus":0.061486399146969926,"score_gpt":0.4884743871861017,"score_spread":0.4269879880391318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908061515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92054003,0.0011802085,0.000011958744,0.010434109,0.0054634768,0.00088103034,0.00025527767,0.00004338819,0.06119054],"genre_scores_gemma":[0.9928008,0.0017250961,0.0006503831,0.002560714,0.0003093528,0.0001069663,0.00006866048,0.000018638282,0.0017593947],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9913035,0.0050713248,0.0016932554,0.00051014574,0.0005806777,0.00084109383],"domain_scores_gemma":[0.9925789,0.0056396187,0.0006451493,0.00046047376,0.00034009104,0.00033575622],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0068590133,0.00020302176,0.0009821551,0.000116313015,0.00016952897,0.0000014479639,0.0003651236,0.0017631655,0.0028678374],"category_scores_gemma":[0.0036485838,0.00017261089,0.00007526361,0.0005472284,0.00019928986,0.000071078095,0.00037375515,0.001649286,0.0006094985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001333781,0.00013980213,0.83643264,0.00016472366,0.000016636597,0.0000824944,0.0009768893,0.0000021859673,0.000030244873,0.0012022011,0.020377545,0.13924086],"study_design_scores_gemma":[0.004119498,0.0011104752,0.9274082,0.0019237858,0.0000065590034,0.000025691888,0.0022371933,0.00011089463,0.000005427474,0.0006502733,0.06224573,0.00015625377],"about_ca_topic_score_codex":0.017561728,"about_ca_topic_score_gemma":0.11187928,"teacher_disagreement_score":0.1390846,"about_ca_system_score_codex":0.0017560626,"about_ca_system_score_gemma":0.00706306,"threshold_uncertainty_score":0.99953276},"labels":[],"label_agreement":null},{"id":"W3010479561","doi":"10.1053/j.seminoncol.2020.02.007","title":"Current and coming challenges in the management of the survivorship population","year":2020,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; National Institutes of Health","keywords":"Survivorship curve; Medicine; Psychosocial; Childhood cancer; Epidemiology; Population; Cancer; Gerontology; Cancer survivorship; Pediatrics; Demography; Environmental health; Psychiatry; Pathology; Internal medicine","score_opus":0.1595619280799779,"score_gpt":0.4339071313693772,"score_spread":0.27434520328939926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010479561","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010669383,0.9902132,7.7633865e-7,0.0052289795,0.0005816544,0.0015351811,0.0000078091325,0.000009141986,0.0013562829],"genre_scores_gemma":[0.0018432672,0.9975464,0.00010843872,0.00016874196,0.00015148785,0.000120384604,0.00002534414,0.000023708311,0.0000122726515],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99685264,0.0013797015,0.00084396556,0.0003835337,0.0003240069,0.0002161414],"domain_scores_gemma":[0.99808013,0.0009326504,0.00046179988,0.0004688127,0.000014841146,0.000041753075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021444357,0.00025190355,0.0015652982,0.00014481299,0.000029419896,0.000004780227,0.00035880398,0.00024307964,0.000006509595],"category_scores_gemma":[0.00013192104,0.00015529197,0.0001763897,0.00040504138,0.00011016371,0.000019593832,0.0002506444,0.0008201202,0.0000023579512],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020430107,0.00014310732,0.0014199954,0.029081464,0.00006138092,0.000041695555,0.003672872,2.0885179e-7,1.1073585e-8,0.0013121548,0.00011663768,0.96413004],"study_design_scores_gemma":[0.00049351045,0.00017316706,0.01305741,0.046816632,0.00045835008,0.000081124235,0.0020878878,0.0000029825665,7.500072e-8,0.00034640497,0.9363453,0.00013720126],"about_ca_topic_score_codex":0.00020930781,"about_ca_topic_score_gemma":0.0019513025,"teacher_disagreement_score":0.96399283,"about_ca_system_score_codex":0.0003326127,"about_ca_system_score_gemma":0.00013077496,"threshold_uncertainty_score":0.63326234},"labels":[],"label_agreement":null},{"id":"W3022810005","doi":"10.1016/s0093-7754(01)90138-1","title":"Surveillance for hepatocellular carcinoma","year":2001,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Cirrhosis; Hepatitis B; Randomized controlled trial; Internal medicine; Intensive care medicine","score_opus":0.1290042608533236,"score_gpt":0.3658405095273251,"score_spread":0.23683624867400152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022810005","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010985153,0.9883201,0.00002608348,0.00017188214,0.00053216267,0.004218915,0.00008018571,0.00006587123,0.0054862434],"genre_scores_gemma":[0.0010110125,0.9903203,0.0014226201,0.00009869555,0.0004973481,0.0019752327,0.0012154304,0.00014010926,0.0033192344],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969091,0.00032584186,0.0009821361,0.000827093,0.00019582533,0.00076005],"domain_scores_gemma":[0.9977129,0.00097086874,0.00035692524,0.00064074097,0.00009421823,0.00022435757],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00077200495,0.0006408933,0.0037937565,0.00052021863,0.00006645563,0.000012733313,0.0002562761,0.0012531431,0.0001838261],"category_scores_gemma":[0.0002029752,0.0005452512,0.0010079067,0.0006884306,0.0001283632,0.000030293004,0.000087449924,0.0005745159,0.00012618086],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081485465,0.00032283526,0.12806997,0.008927564,0.00014349144,0.0032799817,0.000055264154,1.3568644e-8,5.290919e-7,0.000042280833,0.003347484,0.8557291],"study_design_scores_gemma":[0.001462846,0.001404556,0.00007468482,0.005152367,0.000974537,0.0011565374,0.000020560878,0.00013077894,0.000004366095,0.00004880662,0.9891431,0.00042688267],"about_ca_topic_score_codex":0.00005205404,"about_ca_topic_score_gemma":0.00003860905,"teacher_disagreement_score":0.9857956,"about_ca_system_score_codex":0.0011957684,"about_ca_system_score_gemma":0.0011547867,"threshold_uncertainty_score":0.9996999},"labels":[],"label_agreement":null},{"id":"W3094171178","doi":"10.1053/j.seminoncol.2020.10.001","title":"Toward affordable cancer drugs: Do we need firmer price negotiation, me-too drugs, or a biosimilar silver bullet?","year":2020,"lang":"en","type":"editorial","venue":"Seminars in Oncology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Biosimilar; Medicine; Cancer drugs; Negotiation; Cancer; Silver bullet; Drug prices; Pharmacology; Drug; Intensive care medicine; Internal medicine; Public economics","score_opus":0.019932946611267474,"score_gpt":0.3240218381404496,"score_spread":0.3040888915291821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094171178","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016986608,0.07319807,0.000086160646,0.053856835,0.86126435,0.0015730219,0.0011254995,0.00026065798,0.008465516],"genre_scores_gemma":[0.0017257709,0.23273627,0.012397783,0.01645758,0.576769,0.0016899315,0.002246431,0.0007051227,0.1552721],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99394554,0.0011181127,0.001455215,0.001661058,0.00030460468,0.0015154507],"domain_scores_gemma":[0.9929663,0.004859969,0.0008265997,0.00074281555,0.00042350515,0.00018082355],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0013717425,0.0010424736,0.0024022732,0.0004724981,0.00024400289,0.000063850945,0.00133458,0.006678694,0.0075492063],"category_scores_gemma":[0.0024287845,0.0008335852,0.00045465425,0.0011178447,0.00081572495,0.00012052488,0.0006987206,0.00371784,0.00043045348],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021286635,0.000422832,0.00005767263,0.0003332479,0.0006637558,0.0001420377,0.0029824225,0.0000054157376,0.0022610805,0.000096329764,0.972661,0.018245533],"study_design_scores_gemma":[0.003269479,0.0013338991,0.000009395232,0.00065618946,0.0005381171,0.000022030314,0.0022897918,0.000016533106,0.0029509575,0.00059362064,0.98731965,0.0010003551],"about_ca_topic_score_codex":0.00039880638,"about_ca_topic_score_gemma":0.00017207277,"teacher_disagreement_score":0.28449535,"about_ca_system_score_codex":0.0013400064,"about_ca_system_score_gemma":0.0022078285,"threshold_uncertainty_score":0.9994115},"labels":[],"label_agreement":null},{"id":"W3148820128","doi":"10.1053/j.seminoncol.2021.03.001","title":"Can locally developed me-too drugs aid price negotiation? An example of cancer therapies from China","year":2021,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Natural Science Foundation of China","keywords":"Medicine; Gefitinib; Erlotinib; Reimbursement; Public economics; Cancer; Economic growth; Epidermal growth factor receptor; Economics; Health care; Internal medicine","score_opus":0.054499248969912276,"score_gpt":0.3286563674087065,"score_spread":0.27415711843879426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3148820128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96575373,0.00602802,0.00014241299,0.00573608,0.0005822354,0.00013994273,0.00032774,0.000015805826,0.02127403],"genre_scores_gemma":[0.9870002,0.0060898853,0.0028012875,0.0030905704,0.00017745889,0.000049380138,0.00008217266,0.000029470595,0.00067956466],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983766,0.00005370763,0.0007351664,0.000465889,0.00002725901,0.00034138002],"domain_scores_gemma":[0.9989397,0.00022955795,0.00034959114,0.00031925752,0.00004505958,0.00011683316],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042746926,0.00015758195,0.000584742,0.00015220974,0.00005122051,0.000023829767,0.00028758304,0.00019249973,0.0015358073],"category_scores_gemma":[0.00007941341,0.00019410405,0.00006634231,0.0002904719,0.000101413134,0.00012999726,0.000108759916,0.00022398331,0.00004298198],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026486182,0.0012525663,0.4699381,0.000082130005,0.00046864903,0.000056290093,0.056819804,0.0014685713,0.0018877317,0.34217787,0.004031567,0.12155186],"study_design_scores_gemma":[0.002730136,0.00022653166,0.22827345,0.00004782165,0.00001957655,0.000005830975,0.001203572,0.0057272594,0.0038766607,0.19512974,0.5621379,0.00062151946],"about_ca_topic_score_codex":0.014788714,"about_ca_topic_score_gemma":0.007387414,"teacher_disagreement_score":0.5581063,"about_ca_system_score_codex":0.00045675103,"about_ca_system_score_gemma":0.00037031705,"threshold_uncertainty_score":0.99937695},"labels":[],"label_agreement":null},{"id":"W4225147572","doi":"10.1053/j.seminoncol.2022.04.002","title":"Cancer-specific mortality in patients with non-metastatic renal cell carcinoma who have undergone a nephrectomy and are eligible for adjuvant pembrolizumab","year":2022,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Pembrolizumab; Renal cell carcinoma; Nephrectomy; Kidney cancer; Adjuvant; Oncology; Internal medicine; Cancer; Adjuvant therapy; Melanoma; Surgery; Immunotherapy; Kidney; Cancer research","score_opus":0.02166250864591987,"score_gpt":0.2929535457220311,"score_spread":0.27129103707611124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225147572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931666,0.0029861585,0.000024967989,0.00030151417,0.000121182544,0.0020651056,0.000121644865,0.0000130491335,0.0011997343],"genre_scores_gemma":[0.9962644,0.00023658903,0.0010211283,0.00023860678,0.000039838193,0.001371221,0.00013997096,0.00004747015,0.0006407537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978299,0.00017645425,0.00046873276,0.00062985305,0.00035484182,0.0005402148],"domain_scores_gemma":[0.99890727,0.00024140828,0.0002545502,0.0003538808,0.00008522907,0.00015766824],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029396373,0.00028907115,0.00086508295,0.00035219645,0.00011068055,0.000008949255,0.00012087833,0.000082769715,0.00010060714],"category_scores_gemma":[0.000018116458,0.00025499598,0.00006975691,0.00034021254,0.00012907041,0.000054769735,0.00014552526,0.00040633627,0.00000146059],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060141054,0.0013967913,0.9826892,0.00022163564,0.000055744225,0.0010318132,0.001562369,0.00042968415,0.0003163462,0.000010927899,0.0019304805,0.0043408894],"study_design_scores_gemma":[0.023848597,0.0083404025,0.9594918,0.0001571536,0.0001807013,0.0000760721,0.0019034058,0.00066518073,0.0012985037,0.0001021169,0.0036673439,0.00026874559],"about_ca_topic_score_codex":0.00088561757,"about_ca_topic_score_gemma":0.0021302183,"teacher_disagreement_score":0.023197437,"about_ca_system_score_codex":0.002318126,"about_ca_system_score_gemma":0.0005059571,"threshold_uncertainty_score":0.9999902},"labels":[],"label_agreement":null},{"id":"W4234456939","doi":"10.1053/sonc.2002.33538","title":"Epoetin alfa in patients not on chemotherapy [ndash ] Canadian data","year":2002,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Epoetin alfa; Medicine; Anemia; Erythropoietin; Chemotherapy; Internal medicine; Cancer; Quality of life (healthcare); Oncology; Darbepoetin alfa; Hemoglobin; Surgery","score_opus":0.04502290979312209,"score_gpt":0.32040501128027976,"score_spread":0.2753821014871577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234456939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91572815,0.00037147428,1.7959098e-7,0.024809752,0.00029622417,0.00045352182,0.00004223527,0.00001808805,0.058280375],"genre_scores_gemma":[0.9855987,0.0013653683,0.000865767,0.008569319,0.000072472496,0.000021274624,0.00022193514,0.000026038695,0.0032591275],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99871725,0.000066007364,0.0002664011,0.00039103342,0.00014640103,0.0004129016],"domain_scores_gemma":[0.99910027,0.000113553564,0.000051421568,0.00055991934,0.000020656385,0.00015420746],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020570052,0.00015054915,0.00033210692,0.0002443197,0.000031871554,0.0000042161173,0.0001957859,0.0002188676,0.0014017043],"category_scores_gemma":[0.00013052145,0.00013751297,0.000025995249,0.00019987432,0.00008603159,0.000029460552,0.0000449482,0.00029935213,0.00025679855],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025675324,0.0021266304,0.4095911,0.000021323225,0.000022898657,0.0010258637,0.0013564662,0.0000028312243,0.00005267713,0.000046202596,0.12265888,0.46283835],"study_design_scores_gemma":[0.011431582,0.0033373807,0.2437055,0.00039759453,0.000022407923,0.000048798793,0.00033777888,0.0003233504,0.0004362661,0.00004112699,0.73966265,0.00025556824],"about_ca_topic_score_codex":0.011011521,"about_ca_topic_score_gemma":0.048044246,"teacher_disagreement_score":0.6170038,"about_ca_system_score_codex":0.0011126759,"about_ca_system_score_gemma":0.00014642261,"threshold_uncertainty_score":0.9995111},"labels":[],"label_agreement":null},{"id":"W4253118244","doi":"10.1016/s0093-7754(01)90200-3","title":"Docetaxel (Taxotere) shows survival and quality-of-life benefits in the second-line treatment of non-small cell lung cancer: A review of two phase III trials","year":2001,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Docetaxel; Vinorelbine; Medicine; Ifosfamide; Lung cancer; Chemotherapy; Oncology; Internal medicine; Cancer; Phases of clinical research; Surgery; Cisplatin","score_opus":0.1612092728561817,"score_gpt":0.5138659854352491,"score_spread":0.3526567125790674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253118244","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010652273,0.97962844,0.000005617977,0.00020931839,0.00028900598,0.005311103,0.0009977575,0.000004670133,0.0029018326],"genre_scores_gemma":[0.00040286416,0.99660677,0.00037465224,0.00017460808,0.00015517756,0.0011256166,0.00035497954,0.00003448572,0.0007708335],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945167,0.0013650437,0.003100985,0.00046494912,0.00024123001,0.00031113473],"domain_scores_gemma":[0.99435663,0.002521326,0.0023279113,0.0005515564,0.00013368935,0.000108885586],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026288503,0.00047258558,0.0074435687,0.00032979302,0.000024465156,0.0000032114376,0.00020468666,0.0003143983,0.0003556702],"category_scores_gemma":[0.0002620548,0.00028656458,0.00059399207,0.00059226155,0.00014414875,0.000028265898,0.000045620516,0.00025495,6.6565167e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003097288,0.002887952,0.0005823531,0.098383754,0.0006909946,0.00006356101,0.0010651674,0.000002067482,0.000010982287,0.000063963314,0.0002477603,0.8956917],"study_design_scores_gemma":[0.03336781,0.004263818,0.000050570652,0.13039687,0.010068374,0.00006500216,0.00037946342,0.000007892775,0.000053040956,0.000012820432,0.8210079,0.00032641328],"about_ca_topic_score_codex":0.0018330938,"about_ca_topic_score_gemma":0.0038940478,"teacher_disagreement_score":0.8953653,"about_ca_system_score_codex":0.0007367112,"about_ca_system_score_gemma":0.0023822207,"threshold_uncertainty_score":0.99995863},"labels":[],"label_agreement":null},{"id":"W4255539843","doi":"10.1053/sonc.2002.34067","title":"Evidence for erythropoietin as a molecular targeting agent","year":2002,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Erythropoietin; Medicine; Hypoxia (environmental); Cancer research; Signal transduction; Hypoxia-inducible factors; STAT5; Cytokine; Tyrosine kinase; Erythropoiesis; Immunology; Anemia; Bioinformatics; Cell biology; Internal medicine; Biology; Receptor; Gene; Chemistry","score_opus":0.1700107563064165,"score_gpt":0.4648524944731977,"score_spread":0.2948417381667812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255539843","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004589941,0.99206185,0.00017277926,0.0005454326,0.00091936765,0.0018131272,0.000019433866,0.000047511923,0.0043745786],"genre_scores_gemma":[0.00003250245,0.99160963,0.004821365,0.0004054376,0.00044544338,0.00077822537,0.00011304288,0.00008446574,0.0017098571],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997579,0.00020846675,0.0009438462,0.0006118319,0.0001873316,0.0004695518],"domain_scores_gemma":[0.9974599,0.0014674797,0.00043447202,0.00038475698,0.000115520226,0.00013788216],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00063648855,0.00038689226,0.001961746,0.00036844108,0.00006759678,0.00001448657,0.00020615675,0.000583772,0.001079989],"category_scores_gemma":[0.0026540759,0.00033798753,0.0007524053,0.00035143332,0.000097389915,0.000041501935,0.0001021747,0.00081594207,0.00024881822],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048510217,0.00027587306,0.0000029362222,0.0069855587,0.000105818945,0.00080362946,0.00017889935,0.0000024647368,0.00019885188,0.000104112005,0.033491217,0.9578021],"study_design_scores_gemma":[0.00039320093,0.0015978909,2.0992672e-7,0.05908925,0.0008044981,0.000969789,0.00008575763,0.000040037285,0.00008125261,0.00005018913,0.936631,0.000256872],"about_ca_topic_score_codex":0.000036977766,"about_ca_topic_score_gemma":0.0000064203123,"teacher_disagreement_score":0.9575453,"about_ca_system_score_codex":0.0010663618,"about_ca_system_score_gemma":0.00067016314,"threshold_uncertainty_score":0.9999072},"labels":[],"label_agreement":null},{"id":"W4295102979","doi":"10.1053/j.seminoncol.2022.09.002","title":"Impact of the COVID-19 Pandemic on the Wellbeing of International Oncology and Hematology Fellows at the Princess Margaret Cancer Center (PMCC)","year":2022,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pandemic; Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Center (category theory); Hematology; Cancer; Internal medicine; Clinical Oncology; Oncology; Family medicine; Virology; Infectious disease (medical specialty); Disease","score_opus":0.07196332846593904,"score_gpt":0.45046123820903233,"score_spread":0.3784979097430933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295102979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9038054,0.000910367,0.0000034866841,0.092003174,0.00068581436,0.0006836613,0.00008164251,0.0000092264545,0.0018172603],"genre_scores_gemma":[0.98153436,0.0016598513,0.000012546901,0.016047282,0.0000717724,0.00013109096,0.0000117631935,0.00001491244,0.00051640766],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978166,0.0008017344,0.00048046946,0.00027305848,0.00029843042,0.0003296877],"domain_scores_gemma":[0.99595803,0.0030496751,0.00043111126,0.0003847245,0.000063402564,0.00011308334],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013730796,0.00015138189,0.00049626705,0.00014346,0.00021369617,0.0000026288437,0.00042843533,0.00016235012,0.0012069547],"category_scores_gemma":[0.00094520225,0.00007784111,0.00013422155,0.00026151375,0.00059209665,0.000019367873,0.0006547638,0.0007250608,0.0000013540523],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017792521,0.00029844648,0.9705932,0.000081276026,0.00010983496,0.00006228206,0.0051418114,0.00032669576,0.0010829833,0.00066547113,0.013143159,0.006715588],"study_design_scores_gemma":[0.004329626,0.0034731794,0.48631114,0.0001758198,0.000090362555,0.0021916912,0.0025958791,0.00033931457,0.00031156075,0.0007617528,0.49926507,0.000154595],"about_ca_topic_score_codex":0.0028958283,"about_ca_topic_score_gemma":0.007679143,"teacher_disagreement_score":0.4861219,"about_ca_system_score_codex":0.0039219605,"about_ca_system_score_gemma":0.0022888943,"threshold_uncertainty_score":0.99990183},"labels":[],"label_agreement":null},{"id":"W4307160114","doi":"10.1053/j.seminoncol.2022.10.001","title":"IO-IO vs IO-TKI efficacy in metastatic kidney cancer patients: A structured systematic review over time","year":2022,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nivolumab; Internal medicine; Ipilimumab; Cabozantinib; Pembrolizumab; Axitinib; Sunitinib; Renal cell carcinoma; Oncology; Kidney cancer; Hazard ratio; Clinical trial; Progression-free survival; Cancer; Immunotherapy; Overall survival; Confidence interval","score_opus":0.03645426860760719,"score_gpt":0.3739355171632866,"score_spread":0.3374812485556794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307160114","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029538892,0.98448277,1.0980933e-7,0.00020245217,0.00070510915,0.012742806,0.00024723256,0.000040515213,0.0012836094],"genre_scores_gemma":[0.000021530137,0.98834944,0.00021086494,0.0016852514,0.000084386564,0.005911049,0.001657212,0.00016290588,0.0019173842],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99190545,0.0026433284,0.0027814335,0.0010908205,0.0007899886,0.0007889896],"domain_scores_gemma":[0.9949992,0.0017789599,0.001580819,0.0011728643,0.00008518705,0.00038298717],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012556933,0.0010034118,0.009685561,0.000821228,0.000057064393,0.000013455729,0.00055740273,0.00044463648,0.004797931],"category_scores_gemma":[0.0026878163,0.000744077,0.0008706896,0.0013807026,0.00011933694,0.00005509137,0.0003353418,0.0014223527,0.00020979703],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097112956,0.0011235297,0.00009796346,0.8730202,0.00075631926,0.0023335854,0.0002931154,0.0000013768915,4.7443075e-7,0.000008534948,0.013821148,0.10844665],"study_design_scores_gemma":[0.002032413,0.0011835764,0.000052442832,0.47653943,0.008678575,0.00034871246,0.00001353527,0.0000044011626,3.7845717e-7,0.000010036896,0.5107519,0.00038461498],"about_ca_topic_score_codex":0.00018622253,"about_ca_topic_score_gemma":0.00006889077,"teacher_disagreement_score":0.49693072,"about_ca_system_score_codex":0.009335198,"about_ca_system_score_gemma":0.0025900411,"threshold_uncertainty_score":0.99950105},"labels":[],"label_agreement":null},{"id":"W4408324658","doi":"10.1053/j.seminoncol.2025.01.002","title":"Plant polyphenols in gastric cancer: Nature's healing touch","year":2025,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Phytochemicals and Antioxidant Activities","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre","funders":"","keywords":"Medicine; Cancer; Polyphenol; Wound healing; Surgery; Internal medicine; Biochemistry","score_opus":0.028626191522679804,"score_gpt":0.39805690612168926,"score_spread":0.36943071459900945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408324658","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00064969773,0.99034816,0.0000013280849,0.0003338614,0.00068981346,0.00086195883,0.0001345105,0.00003102315,0.006949673],"genre_scores_gemma":[0.00022942296,0.9970799,0.0003044223,0.00038177526,0.00037030454,0.00037743454,0.00016747527,0.00003170983,0.001057571],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978424,0.00015455604,0.0007492994,0.00052876247,0.00016487276,0.0005601358],"domain_scores_gemma":[0.99840474,0.0009410425,0.00026000506,0.00028357835,0.000024256477,0.00008637779],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026422428,0.0003894728,0.0028844064,0.0008366345,0.000025836045,0.000008016947,0.00023143172,0.0012778053,0.000061634935],"category_scores_gemma":[0.00025255926,0.00033267366,0.0002595334,0.00089581375,0.00008705959,0.000033021694,0.0001370572,0.0021947061,0.00000544342],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067125075,0.0002580153,0.00025470692,0.016722037,0.00005948808,0.00077514135,0.00006983565,5.5005034e-7,0.000044522847,0.00010473532,0.004265664,0.9773782],"study_design_scores_gemma":[0.0005858569,0.00018383299,0.000022992863,0.10724718,0.00024650985,0.00037742485,0.000075294716,0.000005043422,0.00005610874,0.00009041313,0.89086556,0.00024378541],"about_ca_topic_score_codex":0.00016685623,"about_ca_topic_score_gemma":0.00022132341,"teacher_disagreement_score":0.9771344,"about_ca_system_score_codex":0.0013704404,"about_ca_system_score_gemma":0.0022462606,"threshold_uncertainty_score":0.99991256},"labels":[],"label_agreement":null},{"id":"W4411991032","doi":"10.1016/j.seminoncol.2025.152386","title":"MicroRNAs: From Bench to Bedside Applications as Breast Cancer Therapeutics","year":2025,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières; Innovation and Economic Development Trois Rivières","funders":"","keywords":"Medicine; Bench to bedside; microRNA; Breast cancer; Oncology; Cancer; Internal medicine; Medical physics; Gene","score_opus":0.017170853052539438,"score_gpt":0.374751117898492,"score_spread":0.35758026484595257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411991032","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002734562,0.9950973,0.00014976031,0.00029391187,0.00033995448,0.0015149944,0.0011573022,0.00001560737,0.0011577243],"genre_scores_gemma":[0.00003941418,0.9925909,0.00083212013,0.00079657754,0.0003859019,0.0019179439,0.0018364718,0.000054079086,0.0015466093],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99796814,0.0002171341,0.0005724344,0.00079814106,0.0000912387,0.00035290557],"domain_scores_gemma":[0.9986707,0.00012882453,0.00026150807,0.00074783136,0.00009574985,0.00009537833],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014633252,0.00039856383,0.00089317514,0.00021688042,0.00005720237,0.00001755822,0.0005963372,0.0009541886,0.0001443416],"category_scores_gemma":[0.000028497749,0.00040258028,0.00025931234,0.0004119107,0.000085454594,0.000002248723,0.0003381837,0.00027254564,0.000089173955],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025568668,0.00013623395,0.000043858774,0.000975269,0.00021000588,0.0000066971793,0.000029910789,0.000007501693,0.0034981093,0.000021652126,0.007143331,0.98790187],"study_design_scores_gemma":[0.00019451889,0.000062469844,0.000051473686,0.003175837,0.00046950977,0.000037331956,0.000021393924,5.488858e-7,0.00053614745,0.00011368559,0.9949848,0.00035228147],"about_ca_topic_score_codex":0.0001689466,"about_ca_topic_score_gemma":0.00035924077,"teacher_disagreement_score":0.9878415,"about_ca_system_score_codex":0.00047479526,"about_ca_system_score_gemma":0.0017889867,"threshold_uncertainty_score":0.9998426},"labels":[],"label_agreement":null},{"id":"W9374102","doi":"","title":"Analyzing Knowledge Management Systems: A Veritistic Approach.","year":2004,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Semantic Web and Ontologies","field":"Computer Science","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Knowledge management; Usability; Personal knowledge management; Computer science; Knowledge engineering; Epistemology; Organizational learning; Psychology; Human–computer interaction","score_opus":0.021243062821472338,"score_gpt":0.2947792621978632,"score_spread":0.2735361993763909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W9374102","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022339536,0.011389415,0.6448044,0.00047145577,0.0021426647,0.00052306836,0.0000011832727,0.00031868083,0.31800956],"genre_scores_gemma":[0.89020455,0.00046589997,0.108716145,0.00007601451,0.000059106096,0.00009018427,0.0000019803733,0.000007762996,0.00037838536],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99872303,0.00010461919,0.00027653138,0.00041740845,0.00009761447,0.00038079073],"domain_scores_gemma":[0.99930143,0.00012757479,0.00006818144,0.00042319216,0.000025491074,0.00005409933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045134992,0.000130718,0.0002960214,0.0002521164,0.000064207845,0.000052848856,0.0008054917,0.000117070966,0.0000016370055],"category_scores_gemma":[0.00004305604,0.00012722999,0.000041303854,0.000499564,0.00008713619,0.00013151496,0.00036945476,0.00014789631,0.0000670434],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018801964,0.0008589468,0.0022745293,0.00030408794,0.00006536149,0.002019601,0.0037535995,0.0036088612,0.00006693338,0.80929536,0.0028786834,0.17485523],"study_design_scores_gemma":[0.028638257,0.0065335673,0.074445575,0.005938565,0.00041048648,0.00788344,0.044692867,0.23163803,0.0010275985,0.16278446,0.42975587,0.0062513095],"about_ca_topic_score_codex":0.00006141201,"about_ca_topic_score_gemma":0.000037989314,"teacher_disagreement_score":0.86786497,"about_ca_system_score_codex":0.00045733567,"about_ca_system_score_gemma":0.000096784264,"threshold_uncertainty_score":0.5188288},"labels":[],"label_agreement":null}]}